Physical Studies of Glycosaminoglycans in Relation to the Adhesion Properties of Human Cancer Cells by Peramo, Antonio
University of South Florida
Scholar Commons
Graduate Theses and Dissertations Graduate School
12-7-2005
Physical Studies of Glycosaminoglycans in Relation
to the Adhesion Properties of Human Cancer Cells
Antonio Peramo
University of South Florida
Follow this and additional works at: https://scholarcommons.usf.edu/etd
Part of the American Studies Commons
This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in
Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact
scholarcommons@usf.edu.
Scholar Commons Citation
Peramo, Antonio, "Physical Studies of Glycosaminoglycans in Relation to the Adhesion Properties of Human Cancer Cells" (2005).
Graduate Theses and Dissertations.
https://scholarcommons.usf.edu/etd/814
Physical Studies of Glycosaminoglycans in Relation to the Adhesion Properties of 
Human Cancer Cells  
 
 
 
by 
 
 
 
Antonio Peramo 
 
 
 
 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy 
Department of Physics 
College of Arts and Sciences 
University of South Florida 
 
 
 
Major Professor: Garrett Matthews, Ph.D. 
William S. Dalton, Ph.D. 
Sarath Witanachchi, Ph.D. 
Myung K. Kim, Ph.D. 
Chun-Min Lo, Ph.D. 
 
 
Date of Approval: 
December 7, 2005 
 
 
 
Keywords:  biopolymer, bioengineering, proteoglycans, heparanase, biophysics 
 
© Copyright 2006, Antonio Peramo 
 Note to Reader 
 
The original of this document contains color that is necessary for understanding the data. 
The original dissertation is on file with the USF library in Tampa, Florida. 
 i
 
 
 
Table of Contents 
 
List of Tables                                                                                                                     iii
List of Figures                                                                                                                    iv
List of Abbreviations                    vi
Abstract                                                                                                                         vii
1. Project Scope 1 
2. Background Elements 6 
 2.1 Cancer, metastasis and proteoglycans 6 
 2.2 Glycosaminoglycans 7 
 2.3 Proteoglycans 12 
 2.4 Heparanase 17 
 2.5 Ligand-receptor density 20 
3. Experimental 22 
 3.1 Surface functionalization 23 
  3.1.1 Introduction 23 
  3.1.2 Experimental procedures for surface functionalization 27 
 3.2 Surface density quantitation of GAGs 35 
  3.2.1 Introduction 35 
  3.2.2 Experimental procedures for density quantitation                                         37 
 3.3 Surface characterization by ellipsometry and AFM imaging 40 
  3.3.1 Introduction 40 
  3.3.2 Experimental procedures for surface characterization by ellipsometry  
    and AFM imaging 42 
 3.4 Static adhesion of cancer cells to the functionalized surfaces 44 
  3.4.1 Introduction 44 
  3.4.2 Experimental procedures for static adhesion of cancer cells to the 
 ii
functionalized surfaces  46 
4. Results and discussion 52 
 4.1 Comments on the functionalization of the surfaces 52 
 4.2 Results of the surface density quantitation of GAGs                                             59 
 4.3 Discussion of surface analysis by AFM and ellipsometry 74 
 4.4 Results of experiments of the static adhesion of cancer cells 83 
  4.4.1 Immunostaining and heparanase activity and determination of cDNA 
transfection conditions 83 
  4.4.2 Static cell adhesion to the different substrates 87 
  4.4.3 Discussion of adhesion by cell line 98 
 4.4.4 Comments of the adhesion of cells by the origin of the cell line 100 
 4.4.5 Discussion of adhesion by type of substrate or surface 103 
4.4.6 Discussion of adhesion by the molecules involved. Heparin and  
    heparanase effects on adhesion 106 
4.4.7 Discussion of the adhesion as a function of polysaccharide charge 
    and chain length 108 
5. Physical model of adhesion using the radius of gyration of the biopolymers 119 
6. Future work 129 
7. Conclusions and key achievements 132 
References  137 
Bibliography 149 
Appendices  151  
Appendix A  Equipment 152 
Appendix B  Detailed steps of the chemical procedures 153 
About the Author End Page
 iii
 
 
 
List of Tables 
 
Table 1. Properties of Glycosaminoglycans  9 
Table 2. Chemical structures of glycosaminoglycans 10 
Table 3. Proteoglycans properties and functions 15 
Table 4a. List of primary antibodies 33 
Table 4b. List of secondary antibodies 33 
Table 5. GAG size and length characteristic data 58 
Table 6a. Surface coverage by [14C]-Formaldehyde radiolabeling of APTES 63 
Table 6b. Surface coverage by [14C]-Formaldehyde radiolabeling of APTES (time) 63 
Table 7. Surface coverage by [14C]-Acetaldehyde radiolabeling of GAGs                      69 
Table 8. Surface coverage by [14C]-Acetaldehyde of control surfaces 73 
Table 9a. Variation of ellipsometric thickness of APTES with concentration and time 78 
Table 9b. Variation of ellipsometric thicknesses of GAGs layers in dry state 78 
Table 10. Experimental and theoretical values of surface coverage for GAGs 81 
Table 11. Preferred substrates for adhesion of cancer cells 102 
Table 12. Calculated values of the radius of gyration 124 
 
 iv
 
 
 
List of Figures 
 
Figure 1. Representation of perlecan, a proteoglycan on the basement membrane  14 
Figure 2. Simplified scheme of the procedure of GAG surface modification 31 
Figure 3. Simplified scheme of the procedure of surface modification HSP  32 
Figure 4. GAGs fluorescence micrographs  55 
Figure 5. AFM surface images of CSA 56 
Figure 6. Simplified scheme of the procedures for quantitation of glass grafted GAGs 61 
Figure 7. Scheme of the procedure for radiolabeling with [14C]-Formaldehyde  62 
Figure 8. Scheme for [14C]-Acetaldehyde radiolabeling of polysaccharide surfaces 66 
Figure 9. APTES control surfaces subjected to hydrozinolysis and deamination 72 
Figure 10. Localization of heparanase in cDNA transfected cells 85 
Figure 11. Heparanase activity and Western Blots. 86 
Figure 12. Absolute adhesion of MCF7 cells 91 
Figure 13. Adhesion of MCF7 cells relative to non-treated cells 91 
Figure 14. Absolute adhesion of A431 cells 92 
Figure 15. Adhesion of A431 cells relative to non treated cells 92 
Figure 16. Absolute adhesion of BT20 cells 93 
Figure 17. Adhesion of BT20 cells relative to non-treated cells 93 
Figure 18. Adhesion of MCF7, BT20 and A431 non treated cells 94 
Figure 19. Adhesion of MCF7, BT20 and A431 heparin suspended cells 94 
Figure 20. Adhesion of MCF7, BT20 and A431 cDNA transfected cells 95  
Figure 21. Absolute number of non-treated cells adhered to glass and APTES 95 
Figure 22. Absolute number of heparin suspended cells adhered to glass and APTES 96 
Figure 23. Absolute number of cDNA transfected cells adhered to glass and APTES 96 
Figure 24. Adhesion vs sulfate per dimer graph for non-treated cells 113 
Figure 25. Adhesion vs sulfate per dimer graph for heparin suspended cells 114 
 v
Figure 26. Adhesion vs sulfate per dimer graph for cDNA transfected cells 115 
Figure 27. Adhesion vs GAG chain length 117 
Figure 28. Plots of adhesion vs Rg of GAGs for non-treated cells 125 
Figure 29. Plots of adhesion vs Rg of GAGs for heparin suspended cells 126 
Figure 30. Plots of adhesion vs Rg of GAGs for cDNA transfected cells 127 
Figure 31. Detailed reaction of silanization with APTES 153 
Figure 32. Detailed reaction of reductive amination with NaBH3CN 154 
Figure 33. Detailed reaction of the procedure for radiolabeling APTES surfaces 155 
Figure 34. Detailed reaction of radiolabeling via enamine  156 
Figure 35. Detailed reaction of proteoglycan binding to APTES  157 
Figure 36. Detailed reaction of denitrosation 158 
Figure 37. Detailed reaction of deacetylation and deamination 159 
 vi
 
 
 
List of Abbreviations 
 
μCP: Microcontact printing 
APTES: 3-aminopropyltriethoxysilane 
BM: Basement Membrane 
BS3: Bis[sulfosuccinimidyl] suberate 
BSA: Bovine serum albumin 
CSA: Chondroitin sulfate A 
CSC: Chondroitin sulfate C 
EDTA: Ethylenediaminetetraacetic acid 
ECM: Extracellular matrix 
GAG: Glycosaminoglycan 
HSP: Heparan sulfate proteoglycan 
HS: Heparan sulfate 
KS: Keratan sulfate 
M.M.: molecular mass 
PDMS: Polydimethylsiloxane 
PG: Proteoglycan 
SAM: self-assembled monolayer 
 vii
 
 
 
Physical Studies of Glycosaminoglycans in Relation to the Adhesion Properties of 
Human Cancer Cells 
 
Antonio Peramo 
 
ABSTRACT 
 
The study of the processes relating glycobiology and cancer will have increased interest 
in coming years. To contribute to this trend the outcome of this work will be useful for 
investigations in glycobiology, using experimental methods exhibiting controlled 
carbohydrate composition, organization, and orientation, drawn from materials science 
and physics and that can be used in bioengineering and other technical areas in biology.  
 
In this work, the focus has been on physical studies of some members of the family of 
glycosaminoglycans and their role in cancer metastasis. The project studies the static 
adhesion of cancer cells to substrates functionalized with cell surface glycocalyx 
molecules and, in particular, in the interaction of heparan sulfate, keratan sulfate and 
chondroitin sulfates with the cells. Surface characterization techniques are used to 
analyze the structure of the polymeric brushes deposited on the substrates. 
 
The hypothesis that the adhesion of whole cancer cells to glysocaminoglycan substrates 
is a function of polysaccharide charge per dimer and chain length was proposed and 
tested. Part of  the work has been dedicated to study the changes in the adhesion of tumor 
cells in the presence of heparanase, an enzyme expressed in the tumor cell surface. 
 
 
 
 viii
The essential achievements of the project have been: 
 
a) Design of a new a method for the deposition and patterning of glycans to glass or 
silicon surfaces functionalized with a silane agent, exposing an amino terminated 
monolayer as functional substrate. 
b) Development of a new method for the calculation of the density of the deposited 
molecules. 
c) Physical characterization of the surfaces using a combination of surface science 
techniques, including ellipsometry and atomic force microscopy. These surfaces 
should be useful for developing additional experiments that may be helpful in 
understanding the adhesive properties of the cells. 
d) Comparative analysis of the behavior of cancer cells to the functionalized surfaces, 
specifically the study of the static adhesion of the cells, in the presence or absence of 
the surface protein heparanase or its inhibitors. 
e) Confirmation of the hypothesis that attachment of whole cancer cells, in vitro, 
depends linearly on the charge per dimer of polysaccharide. 
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1. Project Scope 
 
One of the most critical factors in the malignancy of cancer is metastasis. To metastasize, 
cancer cells must acquire the ability to survive in the bloodstream and invade a foreign 
tissue. Partially, this process is prevented by the propensity of some cells to die in 
suspension. Cancer cells metastasize using not just blood vessels, but other vessels, as 
well as other mechanical processes. For example, the lymphatic system and the 
genitourinary track are also used in the metastatic process.  
 
Carbohydrate to carbohydrate interaction appears to be the initial step in cell adhesion via 
communication between some molecules in the cell glycocalyx and the extracellular 
matrix. The extracellular matrix in animals is made mainly from two main classes of 
macromolecules: GAGs and fibrous proteins like collagen, elastin, fibronectin and 
laminin. These macromolecules provide structural and adhesive properties to the matrix. 
Specialized ECMs are basement membranes acting as a surface where cells can migrate 
and a barrier to cell migration. 
 
The arterial wall contains different GAGs and PGs, like chondroitin sulfate and heparan 
sulfate, and heparan sulfate is found in the endothelial cell surface. Normally, methods to 
deposit glycocalyx molecules have consisted in growing endothelial cells on surfaces and 
then eliminating part of the biological material via lysis. This artificial model has 
permitted testing for adhesion between cancerous cells and GAGs found in the ECM. 
However, that method cannot study individualized interactions between cells and 
molecular species of choice, and developing a new technique that facilitates this analysis 
is within the scope of this project.  
 
 
 2
The physical characterization may be investigated by developing in vitro model surfaces 
containing molecular species of interest with the possibility of selecting the molecular 
composition at the interface. 
 
Characterization of the adhesion processes in which cancer cells make use of the 
polysaccharide chains of proteoglycans – the glycosaminoglycans- is of interest.  It has 
been known for some time that some proteins in cell surfaces bind glycosaminoglycans1. 
For instance, cell adhesion proteins- i.e. integrins, laminin-, glycoproteins of the  
extracellular matrix and others2,3. Where those proteins are found, GAGs are also present 
as side chains of PGs showing differences in their chemical composition. 
 
Some work has been put into studying the effects of an enzyme, heparanase, on the 
adhesion of cancer cells to the GAGs substrates. This secreted enzyme is located on the 
surface of some normal and several tumor cells and can possibly function as a receptor or 
provide the conditions for the adhesion of the cell to the ECM4. Heparanase is known to 
have a role in the metastatic potential of tumor cells5 and several tumors are known to 
show preferential expression of heparanase mRNA6, 7, 8. Zcharia9 has shown that the 
                                                 
1 Lindahl, U; Höök, M., Glycosaminoglycans and their binding to biological macromolecules. Ann. Rev. Biochem. 
1978, 47, 385-417. 
2 Jackson, R.L.; Busch, S.J.; Cardin, A.D., Glycosaminocans: molecular properties, protein interactions, and role in 
physiological processes Physiol. Rev. 1991, 71, 481-539. 
3 Yamada, K.M.; Kennedy, D. W.; Kimata, K.; Prattg, R.M. Characterization of fibronectin interactions with 
glycosaminoglycans and identification of active proteolytic fragments, The Journal of Biological Chemistry, 1980, 
255, 6055-6063. 
4 The possibility of inactive heparanase binding to heparan sulfate in the ECM was proposed by Dempsey L.A.;  
Plummre, T.B.; Coombes, S.L.; Platt, J.L. Heparanase expression in invasive trophoblasts an acute vascular damage. 
Glycobiology, 2000, 10, 467-475. 
5 Parish, C.R., Coombe, D.R.; Jakobsen, K.B.;  Bennett, F. A.; Underwood, P.A., Evidence that sulfated 
polysaccharides inhibit tumor-metastasis by blocking tumor cell derived heparanases. International Journal of Cancer, 
1987, 40, 511-518. 
6 Parish, C.R.; Freeman, C.; Hulett, M.D.,  Heparanase, a key enzyme involved in cell invasion. Biochimica et 
Biophysica Acta Reviews on Cancer, 2001, 1471, 99-108. 
 3
increase of heparanase expression in breast cancer and heparanase expressed on the 
surface of breast tumor cells increase metastasis10. 
 
Localization of the molecule on the cell membrane seems to have a major promoting 
effect on metastasis. Mice injected with melanoma cells incubated with pro-heparanase 
before injection showed a substantial increase in lung colonization11. Parish12 and 
Nakajima 13 have also shown that heparin, an inhibitor of heparanase, reduced the 
incidence of experimental metastasis in high percentages, higher than 90%. 
 
Then, in addition to its role in the degradation of the ECM for the metastatic cellular 
escape from tumors14, 15, it seems there is a possibility of involvement for this enzyme in 
adhesion, and it is interesting to note that, although it has little activity at physiological 
                                                                                                                                                 
7 Friedman, Y.; Vlodavsky, I.; Aingorn, H.; Aviv, A.; Peretz, T.; Pecker, I.; Pappo, O., Expression of heparanase in 
normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence of its role in colonic tumorigenesis. 
American Journal of Pathology. 2000, 157, 1167-1175. 
8 Koliopanos A.; Friess, H.; Kleeff, J.;  Shi, X.; Liao, Q.; Pecker, I.; Vlodavsky, I.; Zimmermann, A.; Buchler, M.W. 
Heparanase expression in primary and metastatic pancreatic cancer. Cancer Research, 2001, 61, 4655-4659.  
9 Zcharia, E.; Metzger, S.; Chajek-Shaul, T.; Friedmann, Y.; Pappo, O.; Aviv, A.; Elkin, M.; Pecker, I.; Peretz, T.; 
Vlodavsky, I. , Molecular properties and involvement of heparanase in cancer progression and mammary gland 
morphogenesis. Journal of Mammary gland biology and neoplasia 2001, 6, 311-322. 
10 Goldshmidt, O.; Zcharia, E.; Abramovitch, R.; Metzger, S.; Aingorn, H.; Friedmann, Y.; Schirrmacher, V.; Mitrani, 
E.; Vlodavsky, I., Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and 
metastasis. Proc. Natl. Acad. Sci, 2002, 99, 10031-10036. 
11 Springer, T., Traffic signals for lymphocite recirculation and leukocyte emigration – the multistep paradigm. Cell, 
1994, 76(2), 301-314. 
12 Cif. note 5, supra. 
13 Nakajima, M.; Nicolson, G.L., Heparanases and tumor-metastasis. Journal of Cellular Biochemistry, 1988, 36, 157-
167. 
14 Liu, D.F.; Shriver, Z.; Venkataraman, G.; El Shabrawi, Y.; Sasisekharan, R., Tumor cell surface heparan sulfate as 
cryptic promoters or inhibitors of tumor growth and metastasis. Proc. Natl. Acad. Sci., 2002, 99, 568-573 
15 Vlodavsky, I.; Friedmann, Y., Molecular properties and involvement of heparanase in cancer metastasis and 
angiogenesis. Journal of Clinical Investigation, 2001, 108, 341-347. 
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pH, heparanase still binds to the cell surface16. That suggests that heparanase may act in 
an adhesive function between tumor cells and the endothelium and this function has been, 
in part, studied in this project, by using cells from three different cultured cancer cell 
lines. The orientation was in the investigation of the binding of the tumor cells to surfaces 
modified with some GAGs.  
 
It has been specifically demonstrated in the past that heparan sulfate plays an important 
role in the motility of some cancer cells, namely in liver metastatic cells from lung 
cancer17. It is known that microvessels in the endothelium of each organ express an 
organ-specific membrane phenotype, providing a basis for organ specific recognition of 
vessels by the tumor cells18. This recognition depends, in part, on the ability of cells to 
roll during the metastatic process. The rolling process involves final recognition of 
binding sites and there is a general consensus that this process, rolling followed by 
adhesion, is needed for extravasation. The arrest can also occur through adhesive bonds 
and several molecules are involved in this process in the endothelium, including 
integrins, selectins and cadherins19.  
 
The adhesion step during rolling is known as transient adhesion. Kojima has compared 
the importance of rolling or transient adhesion to static adhesion20. In the case of integrin 
                                                 
16 Gilat, H.R.; Hershkoviz, R.; Goldkorn, I.; Cahalon, L.; Korner, G.; Vlodavsky, I.; Lider, O. Molecular behavior 
adapts to context - heparanase functions as an extracellular matrix-degrading enzyme or as a T-cell adhesion molecule, 
depending on the local pH. Journal of Experimental Medicine, 1995, 181, 1929-1934. 
17 Tóvári, J.; Paku, S.; Raso, E.; Pogany, G.; Kovalszky, I.; Ladanyi, A.; Lapis, K.; Timar, J., Role of sinusoidal 
heparan sulfate proteoglycan in liver metastasis formation. Int. J. Cancer 1997, 71, 825-831. 
18 Nicolson, G.L.; Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of 
malignant cells at specific secondary sites. Cancer Metastasis Rev, 1988, 7, 143-188. 
19 Orr, F.W.; Wang, H.H.; Lafrenie, R.M.; Scherbarth, S.; Nance, D.M., Interactions between cancer cells and the 
endothelium in metastasis. Journal of Pathology, 2000, 190, 310-329. 
20 Kojima, N.; Shiota, M.; Sadahira, Y.; Handa, K.; Hamori, S.,  Cell adhesion in a dynamic flow system as compared 
to static system. Glycosphingolipid- glycosphingolipid interaction in the dynamic system predominates over lectin- or 
integrin-based mechanisms in adhesion of B16 melanoma cells to non-activated endothelial cells. J. Biol. Chem 1992, 
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adhesion mediated mechanisms the static system seems to be predominant while for the 
selectin adhesion mechanism dynamic adhesion predominates.  
 
Based on the previous discussion, the specific aims of the project are: 
 
1. Perform deposition and covalent attachment of glycosaminoglycans on silicon 
and silanized glass surfaces to simulate the structure of the extracellular 
glycocalyx. The techniques to be used are direct immersion and application of 
a pattern by means of microcontact printing (μCP).  
2. Analysis of the surfaces and depositions. Immunofluorescence assays, AFM 
studies of the coated surfaces for the description of their physical 
characteristics and other surface characterization techniques will be 
performed.  
3. Develop a method to evaluate surface densities of the polysaccharides on the 
surfaces. The method described has the advantage that may be used with any 
polysaccharide patterned to any surface exposing an amino terminated 
monolayer by reductive amination of their galactosamine or glucosamine 
repeating units. 
4. Measure the static binding of cancer cells to substrates functionalized with 
polysaccharides. Particular attention has been put on the interaction with 
heparan sulfate, keratan sulfate, chondroitin sulfate with the surfaces. 
5. Propose and verify a simple model for the adhesion of whole cells to 
polysaccharide substrates in vitro in which the adhesion has a linear 
dependence with the charge per dimer of polysaccharide and a probable 
limiting value in the length of the chain. 
                                                                                                                                                 
267, 17264-17270. 
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2. Background Elements 
 
2.1 Cancer, metastasis21 and proteoglycans 
 
The survival of tumor cells in different tissues after they move from their main tumor 
implicate that they have the ability to recruit vasculature and stroma in those other 
tissues, making the local microenvironment to participate in their own proliferation, by 
selection and proliferation of new tumor cells22. 
 
Other physiological processes in the body also occur with this type of molecular cross-
talk, for instance, during embryogenesis. But only malignant invasion is a persistent 
mechanism, with the activation of the local invasive environment. The whole process 
links the motility, the survival and the proliferation of tumor cells. Adhesive and de-
adhesive interactions occur at the site where tumor cells cross the vessel wall and so the 
junctions between vascular cells are broken or retracted.  
 
A family of proteins known as integrins exists at the junctions between cells and the 
ECM. The rupture of integrin mediated adhesion to the ECM, which is required for 
cellular motility or translocation, can trigger apoptosis if it is not followed by attachment. 
                                                 
21 The metastatic process includes invasion, intravasation, arrest, extravasation and neovascularization and is highly 
inefficient. As described by Weiss, L., ( Metastatic inefficiency, Advances in Cancer Research, 1990, 54, 159-211), the 
extravasation can take place in two ways: by active migration of the cells, sometimes following the pathways of 
leukocytes or by intravascular proliferation of arrested cells with damage to the surrounding vessel, bursting out of the 
blood vessel. This process is facilitated by basement membrane-degrading enzymes released from the cancer cells 
themselves and by the vascular endothelium and are in these processes where proteoglycans play their role. 
22 For a review of the microenvironment in cancer, see Liotta, L.A.; Kohn, E.C., The microenvironment of the tumor-
host interface. Nature, 2001, 411, 375-379. See also, Dalton, W.S. The tumor microenvironment: focus on myeloma. 
Cancer Treat Rev. 2003 1, 11-19 for a review on the tumor microenvironment, drug resistance and cell adhesion. 
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The transition to an invasive carcinoma is then preceded by activation of fibroblasts, 
immune cells and endothelial cells, and with the modification of the adjacent ECM 
membrane. These observations lead to the idea that tumor cells are somehow captured by 
vascular cells during entry and exit from the circulation and that the host interface is 
collaborating in the invasion. 
 
The invasion of other tissues take place when stroma and tumor cells exchange some 
molecules – namely enzymes and cytokines – that modify the local extracellular matrix. 
The degradation of the ECM by various enzymes includes the destruction and 
solubilization of matrix PGs and among them HSP. Important factors for growth and 
angiogenesis are sequestered and stored in the microenvironment surrounding the tumors, 
for instance heparin-binding angiogenic proteins. The release of these proteins produces 
angiogenesis after the destruction of HSP by heparanase.  
 
As mentioned in the introduction stromal therapy has emerged as a new strategy for 
cancer therapy. One of the categories is the use of anti-adhesive molecules where the 
development of PGs-based anti-cancer molecules can fit. The focus for therapies has 
been on blocking cell adhesion and from there the interest on the role that heparan sulfate 
expressed in the surface of tumor cells may have in the adhesion and extravasation of the 
cell, mainly via the proteoglycan syndecan23 and on the role of secreted heparanase in the 
adhesion of the cell by linkage to HS (or other GAGs) in the vascular endothelium.  
 
2.2 Glycosaminoglycans 
 
GAGs are polysaccharides that are found in animal tissues, normally in covalent 
association with protein, known as proteoglycans. Seven types are commonly recognized, 
depending upon the sugar, type of linkage between sugars and number and location of 
                                                 
23 Sanderson, R.D. Heparan sulfate proteoglycans in invasion and metastasis. Cell & Developmental Biology, 2001, 12, 
89-98. 
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sulfate groups. Chemically, glycosaminoglycans are polysaccharides primarily composed 
of the disaccharide repeats D-galactose and D-glucosamine (KS), D- or L-glucuronic 
acids and D-glucosamine (HS) or D-glucuronic acid and D-galactosamine(CSA and 
CSC). Table 1 shows their classification.  
 
These polysaccharide types are distinguished by their monomer composition, by the 
position and configuration of their glycosidic linkages, and by the amount and location of 
their sulfate substituents. All, except one, hyaluronate, are sulfated. Hyaluronate is 
thought to have a role in resisting compressive forces in tissues and joints. The presence 
of carboxyl and sulfation groups makes GAGs highly negatively charged. Sometimes 
called mucopolysaccharides, GAGs are highly viscous and highly hydrophilic. 
 
In this project, the selection of the GAGs have been based on the following criteria: in 
the case of HS, CSA and CSC the reason was that they are present in the arterial wall, 
then possibly involved in the intra or extravasation process. In the case of KS, the main 
reason has been that is the only GAG that does not have an acid as monosaccharide, thus 
greatly differentiating it from the rest. In addition, the whole group shows other 
interesting differences in fundamental properties that may prove useful to discern their 
behavior in the experiments. First, an increase in electronic charge per disaccharide in the 
order KS < CSC ~ CSA < HS and second, an increase in GAG chain length measured by 
the disaccharide number per chain, in the order KS < HS < CSA < CSC. 
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Table 1.  Properties of glycosaminoglycans. (Adapted from Lindahl, Cif. note 1, supra.) with GAGs selected in this 
project in grey. 
 
 
Polysaccharide Mol. wt  
(Daltons) 
Repeating period 
monosaccharides 
Sulfate per 
disaccharide 
unit 
Other sugar 
components 
Occurrence in 
mammalian tissues 
 
Hyaluronate 4 – 8000 D-glucuronic acid 
D-glucosamine 
0 none connective tissues, 
skin, vitreous humor, 
synovial fluid, 
cartilage 
Chondroitin 4 and 
6- sulfates 
5 – 60 D-glucuronic acid 
D-galactosamine 
0.1 – 1.3 D-galactose 
D-xylose 
cartilage, cornea, 
bone, skin, arterial 
wall 
Dermatan sulfate 15 – 40 D-glucuronic acid 
L-iduronic acid 
D-galactosamine 
1.0 – 3 D-galactose 
D-xylose 
skin, heart valve, 
tendon, arterial wall 
Heparan sulfate 6 – 25 D-glucuronic acid 
L-iduronic acid 
D-glucosamine 
0.4 – 2 D-galactose 
D-xylose 
lung, arterial wall, 
ubiquitous in several 
cell surfaces 
Heparin 6 – 25 D-glucuronic acid 
L-iduronic acid 
D-glucosamine 
1.6 – 3 D-galactose 
D-xylose 
lung, liver, skin, 
intestinal mucosa 
Keratan sulfate 4 – 19 D-galactose 
D-glucosamine 
0.9 – 1.8  D-galactosamine 
D-mannose 
L-fucose 
Sialic acid 
cartilage, cornea, 
intervertebral disc 
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Table 2.  Chemical structures of glycosaminoglycans. Abbreviations: GlcUA, glucuronic acid; IdUA, iduronic acid; 
GlcN, glucosamine; GalN, galactosamine; Gal, galactose. (Adapted from Lindahl , Cif. note 1, supra). 
 
 
 
Polysaccharide 
Monosaccharide units 
 
                      A                                                          B 
Substituents 
 
 
 
Hyaluronate 
 
 
 
Chondroitin 4- 
and 6-sulfates 
 
 
 
 
 
Dermatan 
sulfate 
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Table 2 (cont.)  Chemical structures of glycosaminoglycans. Abbreviations: GlcUA, glucuronic acid; IdUA, 
iduronic acid; GlcN, glucosamine; GalN, galactosamine; Gal, galactose. (Adapted from Lindahl , Cif. note 1, supra). 
 
 
 
 
Heparin 
 
 
 
Heparan 
sulfate 
 
 
 
 
Keratan 
sulfate 
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Table 2 shows the chemical structures of GAGs. GAGs are not necessarily multivalent, 
but that possibility exists. The binding of a second (or additional) molecule (or proteins) 
to a GAG has probably a small effect compared to the binding of the first molecule. 
 
Due to this abundant variety, GAGs serve for many functions. These functions are 
diverse and include molecular and cell traffic regulation and help in their guidance of 
cells during migration. Another function is chemical signaling between cells. GAGs are 
essential for maintaining structural integrity of many connective tissues and the binding 
to macromolecules. A large number of macromolecules bind to GAGs. The majority of 
receptors are proteins or proteins conjugates, including the protein of interest in this 
study, heparanase.  
 
The proteolysis of matrix proteins contributes to cell migration in several ways, for 
example: clearing a path through the matrix, expose some sites on the proteins that 
promote cell binding or migration, promote cell detachment or release extracellular signal 
proteins that stimulate cell migration. In other words, GAGs can act as selective sieves to 
regulate the traffic of molecules and cells according to their size, charge or both. When 
specific enzymes remove the GAG chains, the filtering properties of the lamina are 
destroyed. There are various types of binding between GAGs and other macromolecules. 
Cooperative electrostatic binding may involve any number of GAGs. The interaction is 
facilitated by increased charge density of the polysaccharides and stereochemical factors. 
 
2.3 Proteoglycans 
 
Proteoglycans are in a highly hydrated form, making a gel-like substance that resists 
compressive forces and allows diffusion of molecules between blood vessels and the 
surrounding tissue. In a proteoglycan, at least one of the sugar chains must be a GAG. 
They form a heterogeneous group because of the different number and types of attached 
GAG chains. Certain functions of PGs are certainly expressed by the free GAG chain 
itself. However, several activities of the proteoglycan depend on the core protein, 
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although in some cases the core protein just provides a scaffold for the appropriate 
immobilization of the attached GAGs chains. The protein acts as anchor, essential for the 
positioning of the GAG-bound ligand.  
 
In vivo, instead as free polysaccharide chains, GAGs occurs as PGs, where several chains 
are covalently linked with its sugar terminal to a polypeptide core. The linkage region is 
essentially the same in PGs with CS/DS or heparin/HS chains: 
GlcUAβ1,3Galβ1,3Galβ1,4Xylβ3 L-serine bridge between the GAG chain and the 
polypeptide core. Table 3 shows a list of PG with some functional and structural 
characteristics. The classification of PGs is complicated because of the heterogeneity of 
the glycan structures or the presence of different types of GAGs chains bound to the same 
core protein. Using the topographical distribution of the PGs respect to the cell surface, 
PGs are intracellular, on the cell surface and in the extracellular matrix.  
 
Not completely within the scope of this project, some experiments have been performed 
with perlecan, a basement membrane PG present in vascular and epithelial basement 
membranes, having heparan sulfate chains and chondroitin sulfate chains with a protein 
core of around 400 kDa. The three GAG chains of perlecan are located at one end of the 
molecule, as shown in Fig 1. The N-terminal domain, domain I, contains the attachment 
sites for heparan sulfate chains. This region can accept either heparan or chondroitin 
sulfate chains, and the selection is cell specific. Perlecan expression is found mainly in 
mature tissues and is prominent in the endothelial cell basement membrane of all 
vascularized organs, specialy liver, lung, pancreas and kidney.  
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Fig 1. Representation of perlecan, a proteoglycan on the basement membrane. Roman numerals indicate domains. 
SEA, protein module; LA, LDL, receptors; Ig, immunoglobulin; LE, laminin-1; LamB globular module; LamG module 
in laminin-1; NtA, N terminal domain that binds laminin; FS, follistatin-like; ST, serine/threonine rich. 
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Table 3.  Proteoglycans properties and functions. (Adapted from Kjellen et al24). 
 
 
Designation Core Protein 
size (~kDa) 
 GAG chains Functions and characteristics 
 
Extracellular    
Fa
m
ily
 a
 
Cartilage/aggrecan 
 
 
Fibroblast/versican 
 
Endothelial cells 
208-221 
 
 
265 
 
>200 
>100 CS, 20-30 KS 
 
12-15 CS 
 
DS 
 
Mechanical support, regulate cell 
migration 
 
Endothelial regeneration 
Fa
m
ily
 b
 
 
Connective 
tissue/decorin 
 
Cartilage/collagen 
 
 
36 
 
68 
 
 
1CS/DS 
 
1 CS 
 
Modulate collagen fibrillogenesis; regulate 
cell growth 
 
Binds to collagen fibrils 
Fa
m
ily
 c
 
 
Fibroblasts/perlecan 
 
Colon carcinoma cells 
 
250-400 
 
240-400 
 
HS 
 
10-15 HS 
 
Modulate assembly of basement 
membranes 
 
 
 
 
 
 
 
                                                 
24 Kjellen, L; Lindahl, U., Proteoglycans: structures and interactions. Annu. Rev. Biochem. 1991, 60, 443-475. 
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Table 3. (cont.)  Proteoglycans properties and functions. (Adapted from Kjellen et al25). 
 
 
Cell surface    
Fa
m
ily
 d
 
Mammary epithelial 
cells /syndecan 
 
Lymphocytes/CD44 
 
B-cells 
31 
 
 
37 
 
31 
1-2 CS, 1-2 HS 
 
 
CS 
 
CS 
Link cytoskeleton to extracellular matrix 
 
 
Mediate cell adhesion 
 
Antigen presentation 
 
Intracellular    
Fa
m
ily
 e
 
Mast cells/serglycin 
 
Platelets/serglycin 
 
Macrophage cells 
 
 
17-19 
 
 
CD, DS, HS,heparin 
 
Store and modulate activity of granular 
processes. Prevent blood coagulation. 
 
 
 
 
 
 
 
 
                                                 
25 Kjellen, L; Lindahl, U., Proteoglycans: structures and interactions. Annu. Rev. Biochem. 1991, 60, 443-475. 
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The binding of proteins to GAGs is usually cooperative electrostatic binding although 
highly specific binding is also possible. In this type of binding, the polysaccharide 
component cannot be substituted by any other glycosaminoglycan species. One example 
is the binding between heparin and antithrombin. It is obvious that in any interaction of 
the GAGs with other macromolecules, the requirements for specificity regarding 
carbohydrate structure will vary. In general, the binding sites are small tracts of GlcUA 
and iduronic acid residues in some specific arrangements. Electrostatic is the interaction 
between heparanase and GAGs, as is later mentioned. 
 
2.4 Heparanase 
 
Few years ago, some groups26, 27, 28 reported simultaneously the cloning of the mammalian 
version of the enzyme. The enzyme has attracted increased interest due to its relevant 
role in several biological processes. The enzyme is an endo-β-glucuronidase that cleaves 
HS chains at well-defined sites. For HS in the ECM, that produces a degradation of the 
ECM that increases angiogenesis and wound healing by liberating cytokines and growth 
factors bound to HS.   
 
In addition of the degradation of the HS in the ECM, heparanase also degrades syndecan-
129, a proteoglycan found in the cell surface with chains of CS and HS. Heparanase type 1 
(Hpa1) exists as a proenzyme of ~ 65 kDa that requires some proteolytic processing in 
                                                 
26 Vlodavsky, I., Friedmann, Y.; Elkin. M.; Aingorn, H.; Atzmon, R.; Ishai-Michaeli, R.; Bitan, M; Pappo, O.; Peretz, 
T.; Michal, I.; Spector, L.; Pecker, I., Mammalian heparanase: gene cloning, expression and function in tumor 
progression and metastasis. Nature Medicine, 1999, 5, 793-802. 
27 Hulett, M.D.; Freeman, C.; Hamdorf, B.J.; Baker, R.T.; Harris, M.J.; Parish, C.R., Cloning of mammalian 
heparanase, an important enzyme in tumor invasion and metastasis, Nature Medicine, 1999, 5, 803-809. 
28 Toyoshima, M; Nakajima, M.; Human heparanase. Purification, characterization, cloning and expression. J. Biol. 
Chem. 1999, 274, 24153-24160. 
29 Reiland, J.; Sanderson, R.D.; Waguespack, M.; Barker, S.A.; Long, , S. et al., Heparanase degrades Syndecan-1 and 
Perlecan Heparan Sulfate. Functional implications for tumor cell invasion. J. Biol. Chem. 2004, 279, 8047-8055. 
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order to become active, in the form of a heterodymer (protein complex with two different 
polypeptide chains) of two sequences of ~8 kDa and ~50 kDa. Both terminals are 
important for the expression of hpa1 in the cell surface. As previously indicated, the 
presence of hpa1 is a possible indicator of the metastatic potential of a tumor cells, but 
there are no specific levels of hpa1 that may give a reference to consider a cell metastatic. 
It has been described the change from low metastatic tumor cells to highly metastatic 
tumor cells when heparanase is overexpressed in the cells. Human heparanase is 
expressed in normal tissues mainly in placenta, lymphoid organs and during organ 
development because to its angiogenic potential, but it is not, or rarely expressed, in 
mature organs except during tissue repair and regeneration. Hpa1 is not detected in non-
metastatic breast carcinoma cells, but hpa1 expression is increased in breast carcinoma 
cells with increased metastatic activity. These facts give an indication of the possible 
involvement of heparanase in cell adhesion.  Additional evidence  of the possible 
involvement of heparanase in adhesion has been given by other authors. It is know that 
non-anticoagulant species of heparin and polysulfated polysaccharides reduce the 
incidence of metastasis. However, it is not clear if the anti-metastatic activity is due to 
the anti-heparanase activity, in the effect on cell adhesion30 not related to heparanase or in 
the effect of cell adhesion related to heparanase. Miao31 reports that laminarin sulfate had 
no effect on melanoma in relation to endothelial cell adhesion, which is the critical step 
in the extravasation of metastatic cells from the capillaries.  
 
Previously, Parish32 reported that heparanase inhibitors failed to affect adhesion of the 
cells to the vascular endothelium. However, as it was pointed out in the introduction, it 
                                                 
30 Koenig, A.; Norgard-Sumnicht, K.; Linhardt, R.; Varki, A., Differential interactions of heparin and heparan sulfate 
glycosaminoglycans with selectins. Implications for the use of unfractioned and low molecular weight heparins as 
therapeutic agents. J. Clin. Invest. 1998, 101, 877-889. 
31 Miao, H.Q.; Elkin, M.; Aingorn, E.; Ishai-Michaeli R, Stein CA, Vlodavsky I. Inhibition of heparanase activity and 
tumor metastasis by laminarin sulfate and synthetic phophorothioate oligodeoxynucleotides. Int. J. Cancer, 1999, 83, 
424-431. 
32 Cif. note 5, supra. 
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seems also that thought heparanase has little activity at physiological pH, it can work as 
an adhesion molecule at different pH33,34, so the secretion of heparanase seems to be 
important in the adhesion of the cell. The difference between inhibition of heparanase 
activity and adhesion is important. It seems that heparanase inhibition is increased in the 
presence of species containing sulfate groups at both the N and O positions; but O 
sulfation is critical. That could mean that adhesion processes could be interrupted in the 
presence of those species, and not only by change in the pH.  
 
In an apparent contradictory report, more recently Goldsmith35 has indicated that 
heparanase mediates cell adhesion independent of its enzymatic activity, if the expression 
of the enzyme is on the cell surface. Its results show that cell attachment of lymphoma 
cells with heparanase expressed on the surface was not affected after removing 85% of 
all ECM sulfated material from endothelial cells. The results of this work suggest that 
heparanase mediated cell adhesion can happen due to the effect of net cell surface charge, 
after interaction with HS, but not necessarily binding with HS. The work of Sandback-
Pikas36 shows that in human platelets O-sulfate groups and not N-sulfated or L-iduronic 
residues are essential for the recognition by heparanase of the HSP. That presence is 
particularly required on the hexuronic acids. Specifically, substrate recognition by 
heparanase is performed when a 2-O-sulfated hexuronic acid is present, that may be 
either glucuronic or iduronic acid. 
 
Although electrostatic binding does not use (necessarily) the same binding sites when 
heparanase show no enzymatic activity than when it does, it is obvious that this report is 
                                                 
33 Cif. note 16, supra. 
34 Ihrcke, N.S.; Parker, W.; Reissner, K.J.; Platt, J., Regulation of platelet heparanase during inflammation: role of pH 
and proteinases. J. Cell Physiol. 1998, 175, 255-267. 
35 Goldshmidt, O; Zcharia, E.; Cohen, M; Aingorn, H.; Cohen, I.; Nadav, L.; Katz, B.; Geiger, B.; Vlodavsky, I., 
Heparanase mediates cell adhesion independent of its enzymatic activity. FASEB, 2003, 17, 1015-1025. 
36 Sandbäck-Pikas, D.; Li, J-P.; Vlodavsky, I.; Lindahl, U., Substrate specificity of heparanases from human hepatoma 
and platelets J Biol Chem 1998, 30, 18770-18777. 
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significant due to the use of KS, that does not have acidic moieties. An eventual decrease 
of the adhesion of the cell to surfaces functionalized with KS compared to surfaces 
functionalized with other GAGs may indicate that the cell is effectively using heparanase 
as a mediator in the adhesion. However, other explanations are possible, as it will be 
clear in the section of the discussion of the adhesion. 
 
2.5 Ligand-receptor density  
 
Conditions for adhesion and migration of different types of cells have been elucidated in 
the past. As an example for transient adhesion, there is the so-called multistep 
paradigm37. In this paradigm, there are mainly three steps that regulate the adhesion: first, 
the cell within the liquid flow approaches the vessel wall and experience rolling and 
labile adhesion. Eventually, it contacts chemoattractants that induce internal chemical 
changes in the cell and in the membrane producing adhesion molecules that can increase 
adhesiveness and provoke the arrest of the cell. In the case of leukocytes, for example, 
integrins are generated to firmly adhere to the blood vessel.  
 
It is known that the molecular structure and substrate recognition sites of some of the 
molecules involved in vascular cell adhesion and metastatic processes molecules have 
been elucidated, as described in previous sections. Cell adhesion molecules have evolved 
novel binding sites that possess intrinsic association and dissociation constants that 
permit both high-affinity cell-cell interaction and rapid cell migration. 
 
Because the cell adhesion is mediated by an interaction between the receptor on the cell 
surface and the ligand on the substrate, the surface density of both will substantially 
influence the adhesion process38. There are several effects that have been observed that 
                                                 
37 For a review, see Springer, T., Traffic signals for lymphocite recirculation and leukocyte emigration – the multistep 
paradigm. Cell, 1994, 76(2), 301-314. 
38 Wattenbarger, M.R.; Graves D.J.; Lauffenburger, D.A., Specific adhesion of glycophorin liposomes to a lectin 
 21
depend on ligand-density. Cell attachment usually increases with ligand density until a 
maximum located above a threshold value and further increases in ligand density do not 
increase adhesion.  
 
Among the parameters required in several adhesion models are surface density of ligands 
and number of receptors on the cell surface. In dynamic adhesion studies, for instance, 
these parameters are part of the mathematical models39,40 that provide solutions for 
different states of adhesion. The kinetics –rate constants of association and dissociation- 
of the recognition sites are then the parameters that determine cell-cell interactions, 
including cell adhesion. In general, those models are useful for adhesion processes that 
involve specific interactions between the molecules involved. 
 
Here, heparanase density on the cell surface is unknown (as well as the origin of possible 
alternative adhesion processes) and the approach has been to develop a technique for the 
calculation of the surface density of ligands, the GAGs, a parameter useful in the 
calculations of adhesion numbers used in the verification of the hypothesis that cancer 
cells adhere to the substrates with a linear dependence of the charge density per dimer. 
                                                                                                                                                 
surface in shear flow. Biophys. J., 1990, 57, 765. 
39 Bell, G. Models for the specific adhesion of cells to cells, Science, 1978, 200, 618-627. 
40 Chang, K.C.; Tees, D.F.; Hammer, D.A.,The state diagram for cell adhesion under flow: Leukocyte rolling and firm 
adhesion. Proc. Nat. Acad. Sci. 2000, 97(21), 11262-11267. 
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3. Experimental 
 
The equipment used during the experiments is shortly described in Appendix A. In Appendix 
B, diagrams with detailed steps of the chemical procedures used for surface functionalization 
and radiolabeling are included. To better address the objectives of the project, an 
experimental scheme in four parts was followed.   
 
The first step was to address how to deposit the polysaccharides on the surfaces. This part is 
described in the section of surface functionalization. As it is mentioned latter, there is a vast 
experimental work that has been done with surfaces patterned with proteins, lipids and 
aminoacids, either using microcontact printing or by absorption. The method described in 
this project was needed to advance in systematic studies of the adhesion properties of cells in 
relation to their glycan structures. 
 
Calculation of the number of molecules exposed on the surfaces was addressed later, and is 
described in the section of surface density quantitation. The surfaces posed essentially two 
problems: the first is that the molecules are polysaccharides, a group of molecules that lack a 
simple reactive group where fluorophores or other molecules can be attached for easy 
identification. In cases where those molecules are available, it is not always easy to perform 
quantitative calculations. Finally, the analysis has to be performed in 2D surfaces, not in 
solution. The method described performs quantitative analysis of GAGs by a radiolabeling 
technique. 
 
Analysis of the surfaces was performed in the section of surface imaging by AFM and height 
measurement by ellipsometry. The technique deposits a silane agent in an initial layer on the 
surface exposing amino groups, to whom the GAGs can be later covalently linked. To have a 
better understanding of the processes taking place at the interface between the silanized 
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surface and the biological molecules, changes in the silanization conditions and analysis of  
heights of the layers were in place in order to achieve better reproducibility and to increase 
the control in which the molecules are exposed. 
 
The behavior of cells on the surfaces and study of its adhesion was performed in the last 
section. The techniques for adhesion, static adhesion, have the objective of conceptualize 
the adhesion process of the cells to the ECM and, instead of working with a surface with 
all the molecules of the extracellular matrix, only the isolated GAGs are presented for 
attachment to the cell and its behavior evaluated by counting the number of cells attached 
after a specific period of time.  
 
3.1 Surface Functionalization 
 
3.1.1 Introduction 
 
The initial experimental work addressed the deposition of covalently patterned 
glycosaminoglycans on silanized glass surfaces. Patterning of biomolecules onto solid 
substrates has been extensively used in previous years and is of interest for several 
biological applications, including controlled adhesion and growth of cells, surface 
functionalization, biosensors, chromatography and immunoassays41, 42, 43. 
The depositions were performed both by immersion and by application of a pattern by 
means of microcontact printing (μCP44, 45). μCP is part of a broader group of technical 
                                                 
41 Dontha, N.;  Nowall, W. B.; Kuhr, W. G., Generation of biotin/avidin/enzyme nanostructures with maskless 
photolithography Anal. Chem. 1997, 69, 2619-2625. 
42 Homola, J.; Lu, H.B.; Yee, S.S., Dual-channel surface plasmon resonance sensor with spectral discrimination of 
sensing channels using dielectric overlayer, Electron. Lett. 1999, 35, 1105-1106. 
43 Bernard, A.; Delamarche, E.; Schmid, H.; Michel, B.; Bosshard, H.R.; Biebuyck, H. Printing patterns of proteins, 
Langmuir 1998, 14, 2225-2229. 
44 Jackman, R.J.; Wilbur, J.L.; Whitesides, G.M., Fabrication of submicrometer features on curved substrates by 
microcontact printing, Science, 1995, 269(5224), 664-666. 
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methods collectively called soft lithography46. It allows patterning proteins or other 
molecules on some surfaces making them available for chemical reaction with specific 
reactants without the need to use photolithography. There are some advantages: μCP has 
a low capital cost, can be used with several materials and surfaces chemistries and can 
generate patterns in non-planar surfaces. 
 
Microcontact printing (μCP) has been established as a patterning technique delivering 
self-assembled monolayers (SAMs) onto substrates in a simple, rapid and reproducible 
manner.  In the past, patterns of proteins47, lipids48 and aminoacids49 have been created by 
this method. Along with these works, there are extensive studies on adsorption of 
proteins at surfaces50,51 giving clear indication that to date efforts have been focused 
primarily on developing patterned protein surfaces.  
 
However, there are no known reports in the literature on reactive microcontact printing of 
mucopolysaccharides as reported in this project. Given the increasing importance of the  
study of the biological processes of polysaccharides, the introduction of this surface 
functionalization technique will be helpful in expanding the field of glycomics. 
 
 
                                                                                                                                                 
45 Lahiri, J., Ostuni, E.; Whitesides, G.M., Patterning ligands on reactive SAMs by microcontact printing Langmuir, 
1999, 15(6), 2055-2060. 
46 Xia, Y.; Withesides, G.M., Soft Litography Annu. Rev. Mater. Sci. 1998, 28, 153-184. 
47 James, C.D.; Davis, R.C.; Kam, L.; Craighead, H.G.; Isaacson, M.; Turner, J.N.; Shain, W.  Patterned protein layers 
 on solid substrates by thin stamp microcontact printing. Langmuir 1998, 14, 741-744. 
48 Hovis, J.S.; Boxer, S.G. Patterning barriers to lateral diffusion in supported lipid bilayer membranes by blotting and 
stamping, Langmuir 2000, 16, 894-897. 
49 Branch, D.W.; Corey, J.M.; Weyhnmeyer, J.A.; Brewer, G.J.; Wheeler, B.C., Microstamp patterns of biomolecules 
for high-resolution neuronal networks. Med. Bio. Eng. Comput. 1998, 36, 135-141.  
50 Hlady, V.; Buijs, J. Protein adsorption on solid surfaces Curr. Opin. Biotechnol. 1996, 7, 72-77. 
51 Ortega-Vinuesa, J.L.; Tengvall, P.; Lundstrom, I. Molecular packing of HSA, IgG, and fibrinogen adsorbed on 
silicon by AFM imaging Thin solid Films, 1998, 324, 257-273. 
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It was considered necessary to ensure that GAGs were attached to the surface of 
patterned glass cover slips later used in the adhesion. Two possibilities were available: 
using microcontact printing to fabricate a master stamp and make several copies for 
different experiments or avoid the stamping process and simply let the reaction go by 
depositing the reactants on the surface. The first method has better reproducibility and 
control of the experimental process. The chemistry of glass is essentially the same as the 
silicon oxide surface, so these methods also serve to modify the surface of glass 
microscope cover slips, although given the different density of silicon oxide on the outer 
layer on the surface, surface densities will be different. In this technique, the attachment 
of GAGs to the glass surface is produced by reductive amination in a reaction mediated 
by sodium cyanoborohydride (NaBH3CN) in which GAGs are bonded to the surface’s 
NH2 groups. 
 
The structure of the functionalized surface simulates the extracellular glycocalyx, a 
periodic bush-like structure located on the surface of endothelial cells that only recently 
has been recognized to be of great biological importance. The glycocalyx is composed of 
various glycosaminoglycans in the form of proteoglycans. These extracellular matrix 
GAGs provide structural links between fibrous and cellular elements, contribute to the 
viscoelasticity of the glycocalyx, and regulate the permeability of plasma elements within 
the matrix52.  As reported by Weinbaum53, little was known about the glycocalyx until 
recently. Squire54 and co-workers showed that the glycocalyx in essence consists of a 
fibrous meshwork with a 20 nm characteristic spacing with brushes of size ~10-12 nm.  
Models of the glycocalyx structure based solely on lengths of GAGs side chains 
proposed a matrix of 7 or 8 nm gap spacing, which was associated with the disaccharide 
repeat of the GAGs chains. In the simplified process of simulating this structure, the 
                                                 
52 Wight, T.N., Cell biology of arterial proteoglycans. Atherosclerosis 1989, 9, 1-20. 
53 Weinbaum, S.; Zhang, X.;  Han, Y.; Vink, H.;  Cowin, S. Mechanotransduction and flow across the endothelial 
glycocalyx, Proc. Nat. Acad. Sci. 2003, 100, 7988-7995. 
54 Squire, J.M.;  Chew, M.;  Nneji, G.; Neal, C.; Barry, J;  Michel, C. Quasi-Periodic substructure in the microvessel 
endothelial glycocalyx: A possible explanation for molecular filtering?. J Struct. Biol. 2001, 136, 239-255.  
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initially focus is put on a 2D view that, observed from a zenithal position, provides a 
meshwork of the protein terminal chain GAGs. Within this simplification, deposition of 
GAGs monolayers with chains separated by 10 to 20 nm are the target of the presented 
experimental procedures, namely patterning of the GAGs by microcontact printing. 
 
Although the focus will be primarily on the study of glycosaminoglycans, a parallel work 
has been carried out with heparan sulfate proteoglycan, known as perlecan, a protein 
present in the ECM. Perlecan expression is found primarily in mature tissues and is 
prominent in the endothelial cell basement membrane of all vascularized organs, 
specifically liver, lung, pancreas and kidney. Perlecan contains three GAG chains, HS 
and CS chains in different proportions, located at one end of the molecule, as can be seen 
in Figure 1. A deposition of HSP on glass will give  an understanding of the orientation 
of the GAG chains and will provide some insights into the characteristics of the 
deposition of glycoproteins vs. GAGs alone. However, it is important to emphasize that 
HSP can expose for attachment additional amino terminal positions. 
 
The utility of surface attachment of biomolecules for the various applications outlined 
above requires that the molecules retain their activity. Additionally, the attachment 
should be stable over long times under various environmental conditions. In this case that 
means that GAGs will be functional for long periods after the deposition on glass, thus a 
mean has been developed by which to covalently attach the polysaccharides through their 
reducing ends, producing an orientation that mimics that of the GAGs bound to the 
protein backbone of the proteoglycan.  
 
The attachment of GAGs to the glass surface is produced by reductive amination in a 
reaction mediated by sodium cyanoborohydride (NaBH3CN) in which GAGs are bonded 
to the amino terminated monolayer of 3-aminopropyltriethoxysilane (APTES). Two 
different procedures were used: 1) GAGs were transferred to surfaces by μCP and 
covalently bound to an amino-terminated monolayer on glass and 2) GAGs were bound 
to similar surfaces in continuous layers by performing all reactions by complete 
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immersion, without using the polymeric stamp to transfer the polysaccharides. 
Immunofluorescence assays were performed to verify the deposition and the quality of 
the patterns. In addition, AFM imaging of the coated surfaces were performed in order to 
observe some physical characteristics of the deposited GAGs layers. These results serve 
as a primary step in a possible long-term goal of characterizing the mechanical properties 
of GAGs in the glycocalyx and its relation with cellular migration. 
 
Demonstration of successful attachment of GAGs and HSP was done through 
fluorescence microscopy. A biotinylated primary monoclonal antibody was used with 
streptavidin tagged with a fluorophore as the secondary marker, allowing for rapid 
visualization of the quality and extent of the depositions. Further characterization and 
analysis of these nanoscale-modified surfaces was done by means of AFM: surface 
images were taken and the thickness of the deposited layers was measured.  
 
3.1.2 Experimental procedures for surface functionalization 
 
Materials. Glass cover slips (Corning 0211) used for deposition were cleaned with a 
plasma cleaner (Harrick Scientific), rinsed with nanopure water, and dried under a 
filtered N2 stream. Heparan Sulfate (Seikagaku America, M.M. 11 kDa), Keratan Sulfate 
(Seikagaku America, M.M. 13 kDa), Chondroitin Sulfate C (Seikagaku America, M.M. 
60 kDa) and Chondroitin Sulfate A (Sigma Aldrich, M.M. 25 kDa) were the 
polysaccharides used, with Heparan Sulfate Proteoglycan (Sigma Aldrich, M.M. over 
400 kDa). 
 
Surface modification. Silanization of the glass surface with 3-aminopropyltriethoxysilane 
(APTES) was performed as previously described55, with minor modifications. Briefly, 
                                                 
55 Weiping Q.; Bin, X.; Lei, W.; Chunxiao, W.; Danfeng, Y.; Fang, Y.; Chunwei, Y.; Yu, W.  Controlled Site-Directed 
Assembly of Antibodies by Their Oligosaccharide Moieties onto APTES Derivatized Surfaces, J. Colloid Int. Sci. 
1999, 214, 16-19. 
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cover slips were rinsed with ethanol and nanopure water, and placed in a plasma cleaner 
for 45 seconds. Immediately after, the cover slips were incubated in freshly made 0.86 
mM solutions of APTES in ethanol for 15 minutes at room temperature. Afterward they 
were rinsed in ethanol and water (twice). Samples were used immediately. This 
modification produces an NH2 terminated monolayer on the surface. 
 
GAG submersion deposition. The APTES substrates were incubated for 24 hours at room 
temperature in solutions of 0.1 μg/ml of HS, KS, CSA and CSC in PBS with NaBH3CN 
(Acros Organics) at a concentration of 3 μg/ml. After incubation, samples were rinsed 
copiously with water, followed by ethanol and water rinses, and dried under a nitrogen 
stream. In the case of HSP, additional APTES surfaces were modified by first reacting 
0.1 μg/ml solutions of the proteoglycan with the cross-linker BS3 (Pierce Biotechnology) 
for 30 minutes followed by quenching for 15 min. with 1M Tris, following the protocol 
described by the manufacturer. This reaction links primary amines found on the protein 
core backbone of the HSP through BS3 to the primary amine bound to the substrate. At 
this point, all samples were ready for characterization by immunofluorescence or AFM. 
Figure 2 shows a schematic of the reaction. 
 
GAG patterning by microcontact printing. In this experiment GAGs were transferred to 
the glass surface using a PDMS stamp that had been cast from a calibration grid with a 
~1.5 μm spacing between ~1.5 μm wide parallel lines 500 nm in height (pitch ≈ 3 μm). 
Silicon gratings (TGZ03, MikroMasch) were used to cast the PDMS stamp, as described 
elsewhere56. Briefly, PDMS (Sylgard 184, Dow Corning) was prepared with a 10:1 mass 
ratio of base to curing agent. The mixture was poured into the glass container in which 
the silicon grating was placed and allowed to degas overnight in a fume hood. Curing 
was performed at 65º C for at least 2 hours. The patterning of the GAGs on the glass 
surface takes place in the following manner. First, an APTES surface is produced as 
                                                 
56 Harrison, C.; Cabral, J.T.; Stafford, C.M.; Karim, A.; Amis, E.J. A rapid prototyping technique for the fabrication of 
solvent-resistant structures J. Micromech. Microeng. 2004, 14, 153-158. 
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described in the surface modification method. Then, and separately, equal volume 
amounts of the GAG solutions of 0.1 μg/ml and NaBH3CN are mixed, and 20 μl of these 
solutions are deposited on the patterned surface of the PDMS stamp for 15 min.  
 
During this time, and to avoid possible evaporation, the stamp was covered with a 
humidified soft wiper. Later, the solution on the PDMS was removed with a stream of 
nitrogen and immediately put into conformal contact with the APTES functionalized 
glass surface, briefly exerting low pressure to help in the contact. The transfer of the 
patterned biomolecules from the PDMS to the glass took place overnight and afterwards 
experiments on the detection and analysis of the deposition were performed. When 
necessary, the patterned cover slips were stored before use at 4ºC in 0.2μm filtered 
nanopure water. Samples that were used for AFM measurements were dried for 
measurements in air.  
 
Proteoglycan patterning by microcontact printing. In the case of HSP the procedure for 
pattern transfer necessarily was modified. The method of transfer uses a bifunctional N-
hydroxysuccinimide ester (BS3, Pierce Biotechnology, Inc.) that is primary amine 
reactive to perform the cross-linking of the protein. With this reactant, only the amine of 
the aminoacid lysine will give a stable product after reaction, although nitrogen is present 
on the side chains of other aminoacids. First, the crosslinker and HSP were reacted on the 
surface of a patterned hydrophilic PDMS for 30 min, followed by incubation with the 
quenching agent Tris 1M for 15 min. Excess solution was quickly blown off with N2  
stream and immediately brought into conformal contact for 5 min. with the APTES 
functionalized glass and then separated.  
The sample was ready for AFM measurements or immunofluorescence detection. This 
procedure works because the secondary reaction between APTES and the crosslinker can 
be performed at any time after reaction with the HSP. 
 
The following procedure was also tried to deposit HSP, but different attempts failed to 
materialize the pattern on the glass surface. First, crosslinker was reacted on the APTES 
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functionalized glass for 30 min while at the same time HSP was adsorbed on the surface 
of PDMS for 1min. Short times are required for the deposition of a monolayer of product. 
Crosslinker excess and HSP were both blown off of the surfaces by N2 stream and 
immediately brought into conformal contact for 1 min. and then separated. This 
procedure was tried both with and without the addition of the quenching  agent. Initially 
only one ester group react with the amine on the protein, releasing just one succinimide. 
There is a slight possibility that two lysine from two different proteins come close 
together to use both ester groups of the same BS3, but is highly unlikely. The use of PBS 
is to avoid excessive hydrolysis of the BS3 at basic pHs. The reaction is arrested by 
adding Tris, which contains more amino groups, thus using almost all BS3 remaining. 
Other quenching agent that may be used is lysine, which may be added in excess to the 
reaction.  
 
After blowing the reactants, the HSP-linked with half of the BS3 will react with the 
primary amine on APTES, and there is no need for additional whole BS3, giving that the 
ester is already linked to the protein. In addition, there is no need for the presence of the 
quenching agent, given that the interest is in having all proteins containing half BS3 
linked to the APTES. Giving that the BS3 is in huge molar excess, almost all proteins are 
linked with half BS3, thus excess proteins will produce the pattern on the surface by 
being able to find the APTES-NH2.  
 
The above explanation plus the fact that the concentration of cross-linker is kept at very 
low levels shows very clear why the other two reactions do not work. After blowing the 
APTES surface the amount of ester available for reaction is, at a maximum, the number 
of APTES molecules, which is much lower than the number of proteins available. 
Finally, while in the first reaction the ester is free to move in solution to interact with the 
lysine, in the second there is a clear steric restrictions for the lysine and ester to find each 
other. It is possible, however, that at higher concentrations of APTES it would be 
probable to find at least some pattern using the second reaction. As it can be seen later, 
this procedure does not produce these high surface densities of APTES.
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Figure 2. Simplified scheme of the procedure of GAG surface modification. APTES is first deposited to glass using 
ethanol as solvent forming an amino terminated layer that is further modified with different GAGs for 24 hours in the 
presence of cyanoborohydride. 
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Table 4a. List of primary antibodies. 
 
Antigen recognized Label Dilution Host Source 
Heparan Sulfate Biotin 1:50 Mouse USBiological 
Keratan Sulfate Biotin 1:100 Mouse Seikagaiku America 
Chondroitin Sulfate 6 Biotin 1:100 Mouse Seikagaiku America 
Heparan sulfate proteoglycan Biotin 1:50 Rat LabVision 
 
 
 
 
Table 4b. List of streptavidin secondary antibodies 
 
Antigen recognized Fluorophore Concentration / dilution Source 
KS-Biotin  DTAF 4.5 μg/ml Jackson ImmunoResearch 
HS-Biotin Qdot 525 1:50 Qdot Corp. 
CSC-Biotin Qdot 605 1:50 Qdot Corp. 
CSA-Biotin Qdot 605 1:50 Qdot Corp. 
HSP-Biotin Qdot 655 1:50 Qdot Corp. 
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Antibodies and fluorescence microscopy. Glass cover slips functionalized by 
microcontact printing with APTES and GAGs or HSP were subjected to indirect 
immunofluorescence detection. Tables 4a and 4b list the antibodies used. Before the 
addition of primary antibodies, cover slips were subjected to Streptavidin/Biotin blocking 
(Streptavidin/Biotin blocking kit, Vector Labs), as follows. First, cover slips were rinsed 
with PBS and then incubated with streptavidin solution for 15 min, rinsed with PBS and 
then incubated for 15 min with the biotin solution, as recommended by the manufacturer.  
 
Biotinylated primary antibodies were applied to the surfaces as described in Table 4a for 
1 hour. After incubation, samples were rinsed with cold PBS 3x5 minutes. After the 
deposition of primary antibodies, fluorescence labeling was performed for KS with 
DTAF streptavidin labeled secondary antibody (Jackson ImmunoResearch) for 30 min; 
for HS, Qdot 655 Streptavidin Conjugate; for CSC and CSA, Qdot 605 Streptavidin 
Conjugate and for HSP Qdot 525 Streptavidin Conjugate were used. Qdots were 
incubated for 1 hour. After rinsing with cold PBS 3x5 min, samples were taken to an 
inverted epifluorescence microscope (Nikon TE2000) equipped with a QImaging Retiga 
EX Monochrome 12-bit Digital Camera for fluorescence imaging of the reaction between 
GAGs and antibodies. Samples with DTAF fluorophore were mounted with Vector Labs 
Hard Mounting Media H1500, while samples with Qdots were mounted with a solution 
of 90% glycerol in PBS. 
 
AFM surface measurements. The commercial AFM used for surface measurements and 
imaging was an Asylum Research MFP 3D. The silicon cantilevers used (NSC36, 
MikroMasch) had a nominal spring constant of 1.75 N/m and resonant frequency of 155 
kHz. During each experiment, the spring constant and resonance frequency were 
calculated using the built-in-software, according to the thermal response method57. 
Measurements were taken in air. Samples were dried under N2, and images were recorded 
                                                 
57 Wendman, M.A.; Gurley, G.; Elings V.; Walters, D.A.;  Cleveland, J.P.; Thomson, N.H.; Hansma, P.K., Short 
cantilevers for atomic force microscopy, Review of Scientific Instruments, 1996, 67, 3583-3590. 
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immediately. All experiments were performed with bare cantilever tips at room 
temperature.  
 
3.2 Surface density quantitation of GAGs 
 
3.2.1 Introduction 
 
In the previous section, a controlled method for the deposition of glycosaminoglycans 
(GAGs) on glass silanized surfaces was described. In this section a method to evaluate 
surface densities of these polysaccharides on glass silanized surfaces in a reaction with 
enamine formation is presented. The method maybe extended to any polysaccharide  
patterned to silanized surfaces. 
 
Surface coverage is an important parameter in the replication of surfaces with 
immobilized biopolymers. It is always interesting to know how surface coverage affects 
the biological activity of the molecules, and the best replica in these depositions would be 
to obtain surface coverage as close as possible to known values existing in the 
glycocalyx. 
 
In general, covalent immobilization yields extended and uniform surface coverage of the 
deposited molecules. During this work it was necessary to find a non-optical method for 
the quantitation of the surface density of the linked glycosaminoglycans, an important 
parameter in several instances in surface science.  The idea was that a procedure via 
enamine formation could produce a feasibly technique, that works for all type of 
glycosaminoglycans, regardless of disaccharide composition.  Here a simple procedure 
for the quantitation of the surface density of polysaccharides by using a radiolabeled 
aldehyde that reacts with the secondary amine present in the covalent link between the 
surface and the GAG to form an enamine is shown.  
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Methods for detection and quantitation of polysaccharides not in surfaces are available. 
One of the most widely utilized methods for radiolabeling uses NaB 3H4 that reacts with 
the reducing end of the saccharide in equimolar quantities. However, once the GAG is 
already linked to a surface, the reducing end is not available because it has been used for 
the deposition during the reaction that links it to the silane, as described previously.  
 
Tritied sodium borohydride could be used after hydrozinolysis and deamination of the 
chains, as is described later, but there is the inconvenient that that will not work for 
certain type of sugars containing acids as part of their disaccharide structures, for 
instance heparan sulfate or heparin. Other methods are not useful in surfaces or not easily 
implemented to work on surfaces. For instance, HPLC by measuring their UV 
absorbance spectra58, chromophores linked to their reducing ends59, 60 or electrophoresis61.  
 
The main advantage and significance of the method described here is that it only requires 
inexpensive chemicals and a scintillation counter, and provides an easy method to 
quantitate surface densities, as described in a recent report on heparinized surfaces62. In 
contrast, other methods for molecular surface analysis –i.e. confocal microscopy– require 
more complex equipment and expertise. 
 
 
                                                 
58 Toida, T.; Shima, N; Azumaya, S; Maruyama, T.; Toyoda, H; Imanari, T.; Linhardt, R.J. Detection of 
glycosaminoglycans as a copper (II) complex in high performance liquid chromatography, J. Chromatography A, 
1997, 787, 266-270. 
59 Bigge, J.; Patel, T.; Bruce, J.; Goulding, P.; Charles, S.; Parekh, R. Nonselective and efficient fluorescent labeling of 
glycans using 2-amino benzamide and anthranilic acid, Anal Biochem. 1995, 230, 229-238. 
60 Huang, Y.; Merchref, Y.; Novotny, M.,  Microscale nonreductive release of O-linked glycans for subsequent 
analysis through MALDI mass spectrometry and capillary electrophoresis. Anal Chem., 2001, 73, 6063-6069. 
61 Calabro, A.;  Midura, R.; Wang, A.; West, L.; Plaas, A.; Hascall, V.C. Fluorophore-assisted carbohydrate 
electrophoresis (FACE) of glycosaminoglycans. Osteoarthritis and Cartilage 2001, 9, Supplement A, S16-S22. 
62 Kett, W.C.; Osmond, R.I.W.; Stevenson, S.M.; Moe, L.; Coomb D.R., Direct detection of the binding of avidin and 
lactoferrin fluorescent probes to heparinized surfaces. Analytical Biochem. 2005, 339, 206-215. 
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3.2.2 Experimental procedures for density quantitation 
 
Materials. Glass cover slips (Corning 0211) used for deposition were cleaned with a 
plasma cleaner (Harrick Scientific), rinsed with nanopure water, and dried under a 
filtered N2 stream. Heparan Sulfate (Seikagaiku America, M.M. 11 kDa), Keratan Sulfate 
(Seikagaiku America, M.M. 13 kDa), Chondroitin Sulfate C (Seikagaiku America, M.M. 
60 kDa) and Chondroitin Sulfate A (Sigma Aldrich, M.M. 25 kDa) were the 
mucopolysaccharides used. [14C]-Formaldehyde with specific activity 52 mCi/mmol was 
purchased from PerkinElmer. [14C]-Acetaldehyde with specific activity 52 mCi/mmol 
was purchased from American Radiolabeled Company. Radioactivity was measured in 5 
ml scintillation fluid on a Beckman-Coulter scintillation counter. 
 
Surface modification. In this technique, the glass surface is first coated with a monolayer 
of the silane agent APTES. The procedure for the silanization is as described previously 
in Section 3.1.2. “Experimental procedures for surface functionalization”. Briefly, glass 
cover slips were rinsed with ethanol and nanopure water, and placed in a plasma cleaner 
for 45 seconds. Immediately after, the cover slips were incubated in freshly made 0.86 
mM solutions of APTES in ethanol for 15’ and rinsed with ethanol and water. This 
surface modification procedure provides a NH2 terminated layer, which can be mono o 
multilayer depending on incubation times and concentrations.  
 
The interest is in obtaining a good and homogeneous surface coverage, producing 
relatively high concentrations of amino groups on the surface. The APTES substrates 
were then incubated for 24 hours at room temperature in solutions of 0.1 μg/ml of HS, 
KS, CSA and CSC in PBS with NaBH3CN (Acros Organics) at a concentration of 3 
μg/ml. After incubation, samples were rinsed with water, followed by ethanol and water, 
and dried under a nitrogen stream. 
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[14C]-Formaldehyde radiolabeling of silanized surfaces. In separate previous 
experiments, the APTES substrates were labeled as previously described63, with 
modifications. APTES cover slips were covered with 100 μl of a solution of 1 mM 
NaBH3CN, 0.2 mM  14CH2O in CH3CN overnight at room temperature. After incubation, 
samples were thoroughly rinsed with CH3CN first and water afterwards and dried under a 
nitrogen stream. 
 
Deaminative cleavage of N-acetylated glycosaminoglycans . 
After the GAGs were attached to the surface, they were N-deacetylated by treatment with 
hydrazine and then cleaved with HNO2 at pH 4.0 and pH 1.5 64,65. This reaction sequence 
cleaved the glycosaminoglycans at their N-acetyl-D-glucosamine or N-acetyl-D-
galactosamine residues. For N-deacetylation, GAG samples were treated with a solution 
of excess anhydrous hydrazine and hydrazine sulfate, prepared by dissolving 1 mg of 
NH2-NH2. H2SO4 in 1 ml anhydrous NH2-NH2, by depositing 200 μl of the mixture on 
the surfaces. Glass cover slips were placed inside small straight-sided jar glass (Fisher 
Scientific) and heated at 90ºC in a sand bath for 10 hours.  
 
Samples were cooled, rinsed with water to eliminate residual hydrazine and quickly dried 
under a nitrogen stream. Deamination was performed with the addition of HNO2 freshly 
prepared and kept at 0º. Nitrous acid at pH 1.5 was prepared by extracting the supernatant 
of the centrifuged mixture of equal amounts of separately kept and ice cooled solutions of 
H2SO4 0.5M and Ba(NO2)2 0.5M. Nitrous acid at pH 4.0 was prepared by mixing 5 ml of 
5.5M NaNO2 and 2ml of 0.5M H2SO4.  In a first step, samples for all GAGs were 
                                                 
63 Xiao, S-J; Textor, N.; Wieland, M.; Keller, B.; Sigrist, H.; Spencer, N.D. Immobilization of the cell adhesive peptide 
Arg-Gly-Asp-Cys (RGDC) on titanium surfaces by covalent chemical attachment,  J. Mat. Sci. Mater. Med. 1997, 8,  
867-872. 
64 Shaklee, P.N. Conrad, H.E. Hydrazinolysis of heparin and other glycosaminoglycans. Biochemistry 1984, 217, 187-
197. 
65 Shaklee, P.N. Conrad, H.E. The disaccharides formed by deaminative cleavage of N-deacetylated 
glycosaminoglycans. Biochem. J 1986, 235, 225-236. 
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deaminated by with 200 μl of nitrous acid at pH 4.0. In the case of HS samples, an 
additional deamination with nitrous acid at pH 1.5 is necessary. Samples were 
deaminated for 1 hour66. Samples were abundantly rinsed with water to wash off the 
surface the saccharide chains cleaved. Again, samples were dried under a nitrogen 
stream. 
 
Denitrosation of polysaccharide surfaces. Nitrous acid also attacks the secondary amine 
linking the silane and the GAG, forming an N-nitrosamine. Quantitative denitrosation is 
then performed by depositing on the surface, at room temperature and overnight, a 
solution containing an excess mixture of NaN3, SC(NH2)2 and H2SO4 prepared by 
dissolving 7.15 mg NaN3, 85.3 mg SC(NH2)2 and 100 μl H2SO4 in 10 ml acetic acid67.  
 
[14C]-Acetaldehyde radiolabeling of polysaccharide surfaces in the presence of 
cyanoborohydride. The remaining mono or disaccharide substrates were radiolabeled as 
follows. Previously denitrosated cover slips were covered with 200 μl of a solution 
containing 1mM NaBH3CN and 0.2 mM  14CHO14CH3 in CH3CN overnight at room 
temperature. In those conditions the concentrations of acetaldehyde and GAG were in 
molar ratios of 100:1. After incubation, samples were thoroughly rinsed with CH3CN 
first and water afterwards and dried under a nitrogen stream. During reaction, samples  
were kept in a dissecator containing P2O5 to avoid moisture and hydrolysis of the formed 
enamine. 
 
[14C]-Acetaldehyde radiolabeling of control APTES surfaces. Experiments were repeated 
using control APTES surfaces only, with no glycosaminoglycans. One set of samples 
were subjected to hydrazinolysis, deamination, denitrosation and radiolabeling, while 
                                                 
66 Shively, J.E.; Conrad, H.E. Stoichiometry of the nitrous acid deaminative cleavage of model amino sugar glycosides 
and glycosaminoglycuronans Biochemistry 1970, 9, 33-43. 
67 Dix, L.R.; Oh, S.M.N.Y.F.; Williams, L.H. Denitrosation of nitrosamines – a quantitative study. Reactions of N-
Methyl-N-nitrosoaniline, N-Nitrosoproline, Dimethylnitrosamine and N-nitrosoarcosine, J.Chem. Soc. Perkin Trans 2. 
1991, 8, 1099-1104. 
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other set was only subjected to radiolabeling. As additional background control, clean 
glass surfaces were also reacted with [14C]-Acetaldehyde. 
 
3.3 Surface characterization by ellipsometry and AFM imaging 
 
3.3.1 Introduction 
 
In previous sections the techniques used for the deposition of GAGs on glass silanized 
surfaces have been described and a method for quantitation of the density of the 
deposited molecules. In this section the modified surfaces are studied by performing null 
ellipsometry measurements and AFM imaging. All measurements were performed in air.  
 
Patterning of biomolecules onto solid substrates is of interest for several biological 
applications. Given the possibility of commercial applications in which 
mucopolysaccharides can be used as detection agents i.e. in kits for immunoassays and to 
establish a standard procedure for the deposition of GAGs to simplify further analysis, it 
was considered necessary to carry out an additional study to determine the effects on the 
coatings of concentration and incubation time of the silane coupling agent used (APTES) 
that could be helpful for the ulterior characterization of the end-grafted polymer GAGs 
chains using different polymer models and comparison with our experimental results.   
 
Ellipsometry and AFM were used for this characterization. Ellipsometry measurements 
were used to confirm values obtained by AFM for the incompressible layer thickness of 
some of the coatings. Studies of the coated surfaces provided information of the thickness 
of the deposited GAGs layers. Changes and improvements in the deposition technique are 
described, as well as studies analyzing the effect of variation in the concentration of 
APTES, the silane agent used for the functionalization. 
 
The purpose behind the analysis is as follows. Surfaces prepared by covalent 
immobilization have an architecture in which functional interfaces of interest in biology 
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are easily replicated and maintained. However, it is necessary to have good knowledge of 
the processes taking place at the interface between the silanized surface and the 
biological molecules in order to achieve better reproducibility and to increase the control 
in which the final molecule is presented and exposed. Unlike proteins, polysaccharides 
have the advantage that they do not denaturate, thus keeping their biological activity, and 
the covalent attachment impedes molecules washing off the surface as it happens when 
they are not irreversibly adsorbed. This type of immobilization usually yields extended 
and uniform surface coverage of the molecules and our objective is to study the reliability 
and repeatability of the silanization, and the best conditions for the attachment of GAGs.  
 
Following the description of Squire68, the glycocalyx is composed of brushes of 10-12 nm 
width, which correspond to the diameter of the fiber of the core proteins. These brushes 
are spaced at 20 nm from each other. GAG chains seem to be strongly stretched due to 
possible electrostatic interactions with solvent molecules and repulsive interactions 
between dimers in adjacent chains. This picture agrees with studies of nanomechanics of 
human cartilage69 indicating dominance of electrostatic repulsive interactions in GAG-
GAG chains. 
 
The structure of this section is as follows: initially, best conditions for surface 
modification are shown in order to obtain reproducible coatings of a monolayer of 
APTES and this is checked by ellipsometry measurements to get information on the 
height of the brushes of GAGs in dry state and with AFM measurements for one of the 
glycosaminoglycans (CSA). 
 
 
 
                                                 
68 Cif. note 52 supra.  
69 Dean, D.; Seog, J.; Ortiz, C; Grodzinsky, A.J.;. Molecular-level theoretical model for electrostatic interactions 
within polyelectrolyte brushes: applications to charged glycosaminoglycans, Langmuir 2003, 19, 5526-5539. 
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3.3.2 Experimental procedures for surface characterization by ellipsometry and 
AFM imaging 
 
Materials. Glass cover slips (Corning 0211) used for deposition were cleaned with a 
plasma cleaner (Harrick Scientific), rinsed with nanopure water, and dried under a 
filtered N2 stream. Heparan Sulfate (Seikagaiku America, M.M. 11 kDa), Keratan Sulfate 
(Seikagaiku America, M.M. 13 kDa), Chondroitin Sulfate C (Seikagaiku America, M.M. 
60 kDa) and Chondroitin Sulfate A (Sigma Aldrich, M.M. 25 kDa) were the 
mucopolysaccharides used, along with the proteoglycan Heparan Sulfate Proteoglycan 
(Sigma Aldrich, M.M. over 400 kDa). Silicon wafers used in ellipsometry measurements 
were also cleaned in hot piranha solutions. 
 
Procedure for surface modification. Silanization with APTES of the glass surface was 
performed as previously described in section 3.1, with some modifications. Briefly, cover 
slips were rinsed with ethanol and nanopure water, and placed in a plasma cleaner for 45 
seconds. Immediately after, the cover slips were incubated in freshly made 0.43 mM, 
0.86 mM, 2.10 mM, 4.20 mM and 21.0 mM solutions of APTES in ethanol for different 
incubation times at room temperature. Afterward they were rinsed in ethanol and water. 
Samples were used immediately or stored in pure ethanol no longer than two hours 
before ellipsometric measurements. This surface modification procedure provides a NH2 
terminated layer, which can be mono o multilayer depending on incubation times and 
concentrations. Silanization of silicon wafers was performed in the same manner, but 
they were cleaned by immersion in hot piranha solution for 30 minutes, followed by 
water rinses before being placed in the plasma cleaner.  
 
GAGs direct deposition. The APTES substrates were incubated for 24 hours at room 
temperature in solutions of  0.1 μg/ml of HS, KS, CSA and CSC in PBS with NaBH3CN 
(Acros Organics) at a concentration of 3 μg/ml. After incubation, samples were rinsed 
copiously with water, followed by ethanol and water rinses, and dried under a nitrogen 
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stream. At this point, all samples were ready for characterization by ellipsometry or 
AFM. When necessary, cover slips were stored before use at 4ºC. Samples taken to the 
AFM for measurements were dried for measurements in air. 
 
Ellipsometry measurements. For ellipsometric measurements, APTES and GAGs were 
deposited, using the same procedure, on silicon wafers. The thickness of the layers was 
calculated with a null spectroscopic ellipsometer, Rudolph Research III EL, equipped 
with a He-Ne laser of λ = 632.8 nm. The angle of incidence was set at 700 and the 
polarizer angle was 45º. Measurements were taken for samples in air in five spots for six 
separate samples. A thermal oxide layer of ~26 Å covered the native silicon surface.  
 
For the ellipsometric measurements of GAGs layers, the substrate (SiO2 /Si) was 
assumed to be a single layer having a set of optical constants that is a combination of the 
contributions from both silicon and the surface oxide70. Indexes of refraction used were 
taken from the literature or from the manufacturer of the products. Whenever possible, 
those values were checked with a refractometer (Abbe-3L Refractometer, Milton Roy, 
Rochester). Possible decreases in the value of the refractive index were also considered, 
that could happen as a result of disordered layers of product. The accuracy of the 
measurements was +/- 0.1nm. 
 
AFM imaging. The commercial AFM used for surface measurements and imaging was 
Asylum Research MFP 3D. The silicon cantilevers used (NSC12/50, MikroMasch) had a 
nominal spring constant of 0.20 N/m and resonant frequency of 20 kHz. During each 
experiment, the real spring constant and resonant frequency were calculated using the 
built-in-software, according to the thermal response method. For measurements in air, 
samples were dried under N2 and images recorded. All experiments were performed with 
                                                 
70 Wasserman, S.R.; Whitesides, G.M.; Tidswell, I.M.; Ocko, B.M.; Pershan, P.S.; Axe, J.D. J. The structure of self-
assembled monolayers of alkylsiloxanes on silicon: a comparison of results from ellipsometry and low-angle x-ray 
reflectivity, J. Amer. Chem. Soc. 1989, 111, 5852-5861. 
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bare cantilever tips at room temperature. Experiments were performed in triplicate and 
results are given with the corresponding standard errors of means. 
 
3.4 Static adhesion of cancer cells to the functionalized surfaces 
 
3.4.1 Introduction 
 
The final part of the experiments consisted of the study of the static adhesion of three 
cancer cell lines to surfaces functionalized with GAGs. As a secondary study, the 
possible involvement of heparanase in this process was analyzed. Four different 
glycosaminoglycans (heparan sulfate, chondroitin sulfate A, chondroitin sulfate C and 
keratan sulfate) were deposited on glass surfaces that had been previously coated with 3-
aminopropyltriethoxy-silane (APTES), and those substrates were used in static adhesion 
experiments. BT20, a moderately metastatic breast cancer cell line, MCF7 a non-
metastatic breast cancer cell line, and A431, a highly metastatic epidermoid skin 
carcinoma cell line, were selected because of their different metastatic activity.  
 
Static cell adhesion is generally associated with integrins on the cell surface and the 
process may include several other type of molecules, for instance hyaluronan, a member 
of the glycosaminoglycan family71. For cells in the vasculature, for example, the adhesion 
is considered to be a multi-step process, that includes a first rapid contact –of low affinity 
binding that does not involve integrins- followed by a persistent binding –of high affinity 
binding- that is mediated by integrins and that initiates the signaling cascade. During this 
work the static adhesion of selected cancer cells with glycosaminoglycans was 
investigated with attention to the role of heparanase in this interaction.  
 
The experimental approach has been as follows. GAGs were covalently bonded to 
                                                 
71 Zimmerman, E.; Geiger, B.; Addadi, L. Initial stages of cell-matrix adhesion can be mediated and modulated by cell 
surface hyaluronan. Biophys. J. 2001, 82, 1848-1857. 
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previously silanized glass cover slips, using the technique described in previous sections. 
The molecular structure of the functionalized surface can be understood as a reduced 
section of the outer areas of the extracellular glycocalyx or the ECM containing 
proteoglycans.  
 
Adhesion experiments were performed in three different conditions: untreated cells; cells 
suspended in media with heparin and cells transfected with heparanase cDNA to induce 
overexpression of endogenous levels of the enzyme. The first was devised to analyze 
how untreated cells react to the surfaces, mainly by comparing their response with 
respect to each. The last two conditions were used to determine the effect of heparin on 
the adhesion and the possible involvement of heparanase. Previous works involving 
heparanase have been performed usually with transfected cells, generally with 
overexpression of the enzyme. Recently, a model for secreted heparanase uptake on the 
cell surface by binding with heparan sulfate chains was proposed72. A strategy was 
devised to demonstrate if cells showing different levels of heparanase affected the 
number of cells adhering to glycosaminoglycan substrates. 
 
Use of heparin in the experiments is based on the following reasons. Heparin is a well-
known inhibitor of the enzymatic activity of heparanase and its inclusion was justified as 
a control to analyze if inactivation or reduction of the enzymatic activity did not 
substantially affect adhesion, in case heparanase played a role in the binding process. It is 
known that non-anticoagulant species of heparin and polysulfated polysaccharides reduce 
the incidence of metastasis, up to 90% in some cases 73. However, it is not clear if the 
anti-metastatic activity is due to the anti-heparanase enzymatic activity or to another 
effect on cell adhesion74. Miao75 reports that laminarin sulfate had no effect on melanoma 
                                                 
72 Gingis-Velitski, S.; Zetser, A.; Kaplan. V.; Ben-Zaken, O.; Cohen, E.; Levy-Adam, F.; Bashenko, Y.; Flugelman, 
M.Y.; Vlodavsky, I.; Ilan, N. Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans, J. Biol. 
Chem. 279, 44084-44092, 2004. 
73 Cif. note 13 supra. 
74 Cif. note 30 supra. 
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in relation to endothelial cell adhesion, which is the critical step in the extravasation of 
metastatic cells from the capillaries.  
 
In another report, Parish76 shows that heparanase inhibitors failed to affect adhesion of 
the cells to the vascular endothelium. It seems that heparanase inhibition is increased in 
the presence of species containing sulfate groups at both the N and O positions and that O 
sulfation is critical for this process. For this reason, experiments were conducted at 
physiological pH, were the enzymatic activity of the molecule is suspended, but adhesive 
functions are present and, as indicated by Ihrcke77, in physiological conditions heparanase 
inactivation does not affect its binding to heparin.  
 
Although other inhibitors of heparanase have been used, for instance heparan sulfate 
solutions, the attention was on heparin because it has been introduced as a terapeutic 
agent and much interest has been generated with the use of heparin as possible terapeutic 
antimetastatic agent. Heparin is proposed to interfere with the selectin-mediated 
interaction of the cancer cells and their stroma78. This role has been put to work reaching 
even clinical trials with the use of low-weight heparins79. Then, the experiments with 
heparin here will have a dual purpose: observation of a change in the adhesion may be 
due to blocking of cell surface receptors (including heparanase) and/or binding to GAGs 
on the substrates. 
 
3.4.2 Experimental procedures for static adhesion of cancer cells to the 
functionalized surfaces 
                                                                                                                                                 
75 Cif. note 32 supra. 
76 Cif. note 5 supra. 
77 Cif. note 35 supra. 
78 Borsig,L; Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins 
and tumor metastasis. Proc. Natl. Acad. Sci. USA, 98, 3352-3357 (2001). 
79 Varki, N.M.; Varki, A. Heparin inhibition of selectin-mediated interactions during the hematogenous phase of 
carcinoma metastasis: rationale for clinical studies in humans. Semin Thromb Hemost. 2002, 28, 53-66. Review. 
 47
 
Tumor cell lines. Human BT20 breast tumor cells and A431 human epidermoid 
carcinoma cells were purchased from ATCC, while MCF7 breast tumor cells were kindly 
provided by Dr. William Dalton, Moffit Cancer Center. All cell lines are adherent and 
were maintained in tissue culture using the specifications recommended by ATCC. MEM 
medium suplemented with 10% FBS was used for BT20 cells; DMEM supplemented 
with 10% FBS for A431cells and RPMI 1640 supplemented with 5% FBS for MCF7 
cells. Cells were cultured at 37ºC in 5% CO2 atmosphere and harvested using standard 
trypsinization procedures and passaged near confluency. 
 
Reagents and materials.  Glass cover slips (Corning 0211) used for deposition were 
cleaned with a plasma cleaner (Harrick Scientific) or with piranha solution (H2SO4:H2O2 
,70:30 v/v), rinsed with nanopure water, and dried under a filtered N2 stream. Heparan 
sulfate, chondroitin sulfate C and keratan sulfate were from Seikagaiku America. 
Chondroitin sulfate A and Heparin from Sigma Aldrich. Common reagents were from 
Fisher Scientific.  
 
Glass surface modification. The procedure for the silanization was described previously 
in Section 3.1.2. “Experimental procedures for surface functionalization”. Briefly, cover 
slips were rinsed with ethanol and nanopure water, and placed in a plasma cleaner for 45 
seconds or immersed in hot piranha solution for 20 minutes. After rinsing with water, the 
cover slips were incubated in freshly made 0.86 mM solutions of APTES in ethanol for 
15 minutes at room temperature. Afterward they were rinsed in ethanol and water. This 
modification produces an NH2 terminated submonolayer or monolayer on the glass 
surface. Samples were used immediately for adhesion experiments with cells or for the 
deposition of GAGs, as described below.  
 
GAG submersion deposition. This method has been described in Section 3.1.2. 
“Experimental procedures for surface functionalization”. The APTES substrates were 
incubated for 24 hours at room temperature in solutions of 0.1 μg/ml of HS, KS, CSA 
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and CSC in PBS with NaBH3CN (Acros Organics) at a concentration of 3 μg/ml. After 
incubation, samples were rinsed with water and dried under a nitrogen stream. At this 
point, all samples were ready for adhesion experiments. 
 
Heparanase staining. Cell surface expression of heparanase in transfected cells was 
determined by indirect immunocytochemistry as described80 with modifications. Cells 
were first fixed with 3.7% paraformaldehyde for 30’ and later incubated with BSA 2% as 
blocking agent for another 30’. Cells were then incubated overnight at 4ºC with goat,  
anti-human Heparanase 1 HPA1 (C20), polyclonal antibody (Santa Cruz Biotechnology, 
California) diluted 1:50 in PBS and then rinsed with PBS, followed by incubation (1:500 
dilution) for 45 minutes at room temperature with horseradish peroxidase-conjugated 
secondary antigoat antibody  (Jackson Immunoresearch). Color was developed using 
EAC substrate (Lab Vision Corp. California), followed by counter-staining with Mayer’s 
hematoxylin. Cells were visualized using bright field light microscopy with a Leica 
DMLB microscope and photographed with a Diagnostic Instruments RT color camera. 
Controls for negative expression were taken without addition of primary antibody. 
 
Heparanase activity. Activity of heparanase was quantified using a commercial 
presentation of the assay that monitors the degradation of heparan sulfate (Heparan 
Sulfate Enzyme Assay Kit, Takara Mirus Bio, Winsconsin). The method is based on the 
fact that heparan sulfate losses its binding activity to basic fibroblast growth factor after 
degradation by heparanase. The procedure followed the protocol described by the 
company. 
 
cDNA Transfection. The cDNA expression construct81 used in these experiments was 
kindly provided by Professors Robert Parish and Mark D. Hulett, Australian National 
University, Canberra. Human heparanase was subcloned into the EcoRI  site of the vector 
                                                 
80 Cif. note 7 supra. 
81 Cif. Note 27 supra. 
 49
pCDNA3. After plasmid recovery82, competent bacteria cells were transformed and DNA 
obtained for transient transfection of the cancer cell lines. Optimization of cDNA 
transfection conditions was performed by incubating all cell lines with 1.5 μg of DNA 
per million cells in 10 cm dishes for 24, 36 and 48 hours to produce Western Blots. 
Maximum efficiency of transfection was assigned to cells transfected for 24 hours for 
A431 and BT20 cells, and for 36 hours for MCF7 cells. In all cases, appropiate amounts 
of FuGene transfection reagent (Roche Diagnostics, Indiana) with ratio 1 μg DNA:4 μl 
reagent were used. After selection of appropiate time, and for adhesion experiments, the 
corresponding amounts of DNA were used for transfection of culture flasks where cells 
were incubated for 24 or 36 hours at 37 °C and transfected with the appropiate amount of 
FuGene reagent in serum free media, as per manufacturer instructions.  All adhesion 
experiments of cDNA heparanase transfected cells were performed using transiently 
transfected cells with the times previously indicated. 
 
BFA incubation. Lysates for Western Blots were obtained for all cell lines with cells 
treated with 10 μg/ml of Brefeldin A (Fluka) for 3 hours in 10 cm dishes with near 
confluent cells.  
 
Western Blots. Heparanase presence in tumor cells was also detected using Western 
Blots. For immunoblotting, cells were incubated in the following conditions: control (no 
transfection); control cells (no transfection) incubated for 3 hours previous lysis with 
Brefeldin A; and cDNA transfected cells incubated for the specified times. After 
incubation the medium was collected and cells were washed with PBS twice. Lysates 
were prepared using RIPA buffer (solution containing 50mM Tris pH 8, 200 mM Nacl, 
5mM EDTA, 1% Igepal, 0.5% sodium deoxycholate and 0.1% SDS) supplemented with 
protease inhibitors (Roche Diagnostics). Lysates were then subjected to SDS-PAGE (4-
12% Tris Acetate Gel membranes NuPAGE, Invitrogen) and transferred to nitrocellulose 
membranes. Proteins were probed against goat, anti-human Heparanase 1 HPA1 (C20), 
                                                 
82 Rosman, G.J.; Miller, A.D. Improved method for plasmid shipment. Biotechniques. 1990, 8, 509. 
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polyclonal antibody (Santa Cruz Biotechnology, California) at 1:100 dilution for 1 hour 
at room temperature, followed by incubation at 1:10000 dilution for 45 minutes at room 
temperature with horseradish peroxidase-conjugated secondary antigoat antibody  
(Jackson Immunoresearch). 
 
Static cell adhesion assays. Adhesion assays were performed using confluently grown 
tumor cells, in three different groups. In one set, heparanase cDNA transfected cells were 
used. In another set, cells non-transfected were used. In a third set, non-transfected cells 
were resuspended in heparin containing media, as described below. 
 
Cells were detached from culture flasks with trypsin and resuspended in the 
corresponding complete media (for cDNA transfected or non transfected) or in a solution 
of complete media containing 10 μg/ml of heparin for especific assays with heparin. 
Trypsin inactivates the enzimatic activity of heparanase, (t1/2= 5h) but that was not 
relevant in our assays. The solutions were always kept warm at 370C. Cells resuspended 
in heparin containing solution were incubated for 30’ in an incubator previous to the 
assay. Cells then were transferred to either clean cover slips, APTES only coated cover 
slips or GAGs coated cover slips placed on the bottom of Petri dishes. The cover slips 
were previously coated with APTES or GAGs as described and were kept warm at at 
370C prior use. Deposited cells were allowed to incubate at 370C  for 2 hours for A431 
and BT20 cells and 8 hours for MCF7 cells. Seeding time was determined by comparing 
the number of cells adhered at 30’, 1h, 2h and 4h (for A431 and BT20) and between 4, 6, 
8 and 10 hours (for MCF7), and selecting between the times that showed stable trend of 
adhesion, determined by 15% or less difference in the number of cells adhered. For BT20 
and A431, seeding time was decided to be 2 hours, while for MCF7 was 8 hours. These 
are the times used in the adhesion experiments. 
 
The number of cells originally deposited on each cover slip was 2.5x105. Cells were 
carefully washed with PBS kept at room temperature to remove non-adherent cells. The 
remaining cells were detached using 250 μl of a solution of PBS-EDTA and then 
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counted. For each experimental group, the results are expressed as the mean percentage 
(+/- SD) of bound tumor cells in 9 cover slips. Given that the whole surface of the cover 
slips had been previously coated with APTES the values shown were compared relative 
to the values found for APTES surfaces. An additional control was performed using clean 
glass cover slips. 
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4. Results and discussion  
 
In this section a detailed discussion of the results obtained in the experiments is 
presented.  
 
4.1 Comments on the functionalization of the surfaces 
 
Surface modification and GAGs deposition. Silanization in ethanol was chosen because 
the same procedure in aqueous media yields a low surface concentration of amines83. This 
deposition of APTES produces a monolayer or submonolayer of the product on the 
surface. The thickness of the layers of silane depositions and the number of reactive -NH2 
groups present on the surface have been quantified previously84. To avoid APTES 
polymerization, the concentration of APTES was kept at the low level used. As can be 
seen in the AFM images in Figure 5, APTES aggregates  are not observed over the glass 
surface. APTES multilayer formation could result in undesirable aggregates, giving 
unreliable results in force measurements. Work with increasing concentrations of APTES 
will show that is not convenient to work with APTES multilayers to perform GAG 
depositions. 
 
μCP. The use of 1.5 μm gratings is justified because resolving features at this length 
scale is more than sufficient for most applications in cell biology and biosensing. PDMS 
stamps were plasma cleaned before deposition of biomolecule solutions to make them 
hydrophilic and to increase wettability. This is an important step in cases were aqueous 
solutions of biomolecules are used and that provides a more efficient transfer of the 
                                                 
83 Cif. note 63 supra. 
84 Cif. note 55 supra. 
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GAGs to the functionalized glass surface. The polymeric stamp makes good conformal 
contact with the APTES-glass substrate, resulting in the relief pattern of its surface being 
translated to the glass as a pattern of GAG molecules. In all cases, GAGs have been 
covalently bonded providing long-term fixation to the surface. Evidence of covalent 
binding is indirect, deriving from control experiments in which the stamping process was 
carried out in the absence of either the APTES monolayer or the catalyst 
cyanoborohydride.  
 
The covalent attachment compares favorably with the process of physical adsorption –
physisorption- in that many biomolecules, such as peptides or oligonucleotides, do not 
retain activity after the surface adsorption process. However, it must be noted that the 
potential effects of adsorption of GAGs to PDMS have not been tested. An additional 
advantage of the covalent bonding is that in most instances the performance of patterning 
in fixation of the molecules is higher than with coating and similar or better than 
immersion. It is important to note that the pattern generated remains even after 1) 
sonication in saturated salt solution for 24 hours and 2) after contact mode and lateral 
force microscopy is performed over several hours of work, abrading the patterned surface 
with the cantilever tip. 
 
Immunofluorescence. Figure 4 shows fluorescence images that reveal the pattern of the 
GAGs by DTAF (for KS) or Quantum Dots (in all other cases). In all cases, the pattern 
formed shows high contrast and resolution. The ~ 1.5 μm wide lines were transferred 
over distances of many tens of hundreds of microns. No diffusion of the molecules into 
the open spaces of the pattern is observed, and the edges of the pattern are very well 
defined at this scale. The use of biotinylated mAb and the use of DTAF labeled 
streptavidin provided an efficient method for immunofluorescence detection of the 
pattern, based on the strong affinity of the biotin-streptavidin binding. Streptavidin 
conjugated Quantum Dots provided also a variation of the method that allowed 
photographic imaging of the detection at different wavelengths. In one of the cases (CSA, 
Fig 4.E) it is possible to observe a small increase in the thickness of the patterned lines. 
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This is due to the process of exerting low pressure between the glass and the patterned 
PDMS stamp when in conformal contact. Further experimentation using defined forces 
will give a standard procedure to overcome this difficulty. Both the PDMS stamps and 
silicon gratings can be reused. To avoid dropouts in the pattern, PDMS stamps were 
cleaned in a sonicator for 30 min in ethanol, while the silicon gratings were also 
sonicated in pure acetone for 30 min. after their use. However, defects can be found in 
the pattern, possibly indicating incomplete cleaning of the stamp prior to use. 
 
As mentioned earlier, control experiments were carried out to eliminate the possibility of 
GAGs being adsorbed on the glass surface, instead of covalently linked. 
Immunofluorescence control experiments were performed with the following sample 
types: clean glass with no deposition of GAGs; glass functionalized with APTES with no 
deposition of GAGs and APTES functionalized glass with a deposition of GAGs without 
the reactive NaBH3CN. All cases tested negative to the presence of patterned GAGs by 
immunofluorescence detection and by surface analysis by AFM. 
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Figure.4. GAGs fluorescence micrographs. In all cases, products were deposited on a monolayer of APTES 
functionalized glass cover slip and reacted with specific biotinylated monoclonal primary antibodies (See text). A) 40X 
epifluorescence microscopy image of KS with DTAF labeled streptavidin. DTAF is a fluorescein derivative with the 
same emission and excitation wavelengths. B) 40X epifluorescence microscopy image of HS with Quantum Dot 655 
labeled streptavidin. C) 40X epifluorescence microscopy image of CSC with Quantum Dot 605 labeled streptavidin. D) 
63X epifluorescence microscopy image of HSP with Quantum Dot 525 labeled streptavidin. E) 63X epifluorescence 
microscopy image of CSA with Quantum Dot 605 labeled streptavidin. The pitch of the lines on all patterns is ≈ 3 μm 
B A 
C D 
E 
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Figure 5. AFM surface images of CSA. Selected tapping-mode topographic AFM images in air of deposited layers of 
CSA on APTES functionalized surfaces, with cantilevers described in the text. A) 20 x20 μm scan and 6 nm z-scale, 
scan rate 1kHz and B) 10x10 μm scan. The free amplitude of the cantilever was chosen to be about 100 nm. Two 
samples were analyzed and for each sample, measurements were taken at two different positions. 
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AFM imaging.  AFM images of cover slip surfaces of one the GAGs, CSA, were 
collected, and the patterned structures are shown in Figure 5. Table 5 shows a theoretical 
calculation of the contour lengths of the GAGs, where estimated values of the molecular 
mass of the products indicated by the manufacturers were used. For the number of 
sulfates per disaccharide unit, Lindahl85 was used as a primary source to calculate 
molecular mass of dimers. The estimation assumes a mean disaccharide monomer length 
ranging from 1 nm, using values from Squire86,  to 1.28 nm87, reported in the CS-GAGs 
present in aggrecan in the cartilage, althought calculations made using data reported by 
Arnott and Scott 88 and from Rees89 give values between 0.92 and 1.16 nm, more in line 
with the 1 nm estimate. 
 
Analysis of cross-sections for CSA, as shown in Fig.4, gave a mean deposited height of 
2.1 +/- 0.6nm. For measurements in air, this height can be considered the thickness in the 
dry state for CSA. Given our contour lengths and GAGs chain molecular weights, our 
results are within the range of values reported by Seog and co-workers who used CS 
chains with contour lengths of 35 nm and indicated an estimated value of 1.5 nm for the 
incompressible layer thickness of the GAG in air using AFM isoforce imaging, while 
reporting a value of 3.18 nm by ellipsometry. 
                                                 
85 Cif. note 1, supra 
86 Cif. note 52, supra 
87 Seog, J.; Dean, D.; Plaas, A.H.K.; Wong-Palms, S.; Grodzinsky, A.J.; Ortiz, C. Direct measurement of 
glycosaminoglycan intermolecular interactions via high-resolution force spectroscopy. Macromolecules 2002, 35, 
5601-5615. 
88 Arnott, S.; Scott, W.E, Accurate X-ray diffraction analysis of fibrous polysaccharides carrying pyranose rings. Part 
I. The linked-atom approach. J. Chem.Soc. Perkin Trans. 2 1972, 324-334. 
89 Rees, D.A. Conformational analysis of polysaccharides. Part II. Alternating copolymers of the agar-carrageenan-
chondroitin type by model building in the computer with calculation of helical parameters,  J. Chem Soc (B) 1969, 217-
226.  
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Table 5. GAG size and length characteristic data. Lc is the total (contour) length in nanometers. 
 
 
 M.M. (kDa) Estimated dimer 
M.M. (Da) 
# Disaccharides 
per chain 
Lc (nm) 
KS 13 403 32 32 to 42 
CSC 60 456 131 131 to 171 
CSA 25 456 54 54 to 70 
HS 11 496 22 22 to 29 
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4.2 Results of the surface density quantitation of GAGs 
 
The general schematic of the method developed to evaluate the surface density of GAGs 
is shown below in Fig. 6 containing a total of six steps that are summarized as follows: 
 
1. After cleaning, the surface is silanized using APTES at concentrations of 0.86 mM 
for 15’. 
2. Immediately after, GAGs are deposited by reductive amination with 
cyanoborohydride for 24 h. 
3. GAGs chains contain acetamido groups that are eliminated by hydrazinolysis at 90ºC 
for 10 h. 
4. Deaminative cleavage of the GAG chains is performed with nitrous acid for 1 h. For 
HS, an additional step is necessary at lower pH for full chain cleavage. 
5. At this point there is only one remaining disaccharide whose bond with the silane has 
to be denitrosated overnight. 
6. Radiolabeling is performed using an aldehyde overnight in a reaction with enamine 
formation. 
 
First part: [14C]-Formaldehyde radiolabeling of silanized surfaces. 
This procedure is well known and based on the reaction of primary amines with ketones 
or aldehydes to produce imines or secondary amines to produce enamines. In the first 
case, the Schiff base (imine) is then converted to a secondary amine with 
cyanoborohydride, a very mild reductor that readily reduces the Schiff base but not the 
aldehyde or ketones. The reaction takes place at neutral pH and is shown in Figure 7. The 
use of sodium borohydrade has essentially two disavantages: the reaction depends on pH 
and its strong reductive action reduces formaldehyde to methanol. 
 
Under ideal conditions, and assuming that all sites available on the glass surface react 
with the silicon to form a perfect monolayer, with a distance for the Si-O-Si bond of 5.0 
Å with a linear chain of propilamine, the maximum density of available amine terminals 
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for reaction with GAGs will be around 2 sites/nm2, which in this ideal situation seems 
high compared with the density in the glycocalyx. As it is shown later in the section of 
ellipsometry thickness, the experimental limitations permit a surface density of  ~ 0.08 to 
0.16 sites/nm2 for APTES. With the technical method described, this would be a good 
approximation to produce an APTES substrate as base for the replication of an actual 
glycocalyx meshwork. This good replica could then be used for studies of the mechanical 
properties of the molecules in simulated physiological conditions. 
 
0.86 mM solutions of APTES had been used during the work with GAGs to prepare the 
surfaces. Here, radiolabeling was performed on surfaces at four different concentrations, 
as shown in Table 6a. The experimental methodology followed the description of Xiao, 
but keeping the ratio of sodium cyanoborohydride / formaldehyde as low as possible for 
maximum efficiency, as described by Jentoff. The objective is to have 1 molecule 
incorporated for every 12 added. 
 
For calculations, the initial assumption was made that the surface was covered with 2 
sites/nm2 in a cover slip with an area of 5.06 x 10-4 m2, that is equivalent to 1.677 
nanomol of APTES, and that reaction GAG:APTES was 1:1. The reaction mediated by 
cyanoborohydride is slow and has to be done overnight allowing for slow evaporation of 
the solvent from the surface at room temperature. The ratio of cyanoborohydride / 
formaldehyde was 5 to 1. 
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Figure 6. Simplified scheme of the procedures for quantitation of glass grafted glycosaminoglycans. 
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Figure 7. Scheme of the procedure for radiolabeling the silane surface with [14C]-Formaldehyde. APTES surfaces 
prepared with different concentrations or times (as shown in Table 6a and 6b) were used in the experiment. 
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Table 6a. Surface coverage by [14C]-Formaldehyde radiolabeling of APTES (concentration). Time for deposition 
was 15’ in all cases.  
 
 
APTES concentration 0.43mM 0.86 mM 2.10 mM 4.20 mM 
Surface density (sites/ nm2) 0.10 +/- 0.03 0.14  +/- 0.01 0.16  +/- 0.02 0.14  +/- 0.02 
 
 
 
 
Table 6b. Surface coverage by [14C]-Formaldehyde radiolabeling of APTES (time). APTES concentration for 
deposition was 0.43 mM in all cases. Mean value of two samples. 
 
 
Time 15’ 1 hour 4 hours 12 hours 
Surface density (sites/ nm2) 0.09 0.10   0.09   0.09   
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The thickness of the layers of silanes depositions and the number of reactive NH2 groups 
present on the surface have been quantified previously by Xiao, with a value of 0.5 nm 
and a surface coverage of 0.22 nMol NH2 groups per cm2 for a submonolayer of product 
(approximately 1.3 amino terminals per nm2) using a concentration of 2.15 mMol of 
APTES and incubation time of 3 hours in dry toluene with reflux. Then the method 
presented here yields surface densities ten times lower, essentially because refluxing dry 
toluene was not used. 
 
An additional analysis was performed varying the time of APTES deposition before 
radiolabeling. It is known that increasing deposition times increases the amount of 
APTES on the surface, generally by forming succesive layers over time. This fact is 
demonstrated in Table 6b where increased times, up to 12 hours, of incubation do not 
produce significant variation on surface densities. That means that the structure of the 
amino layer presented by the surface does not have a significant change, at least respect 
to the ability of small molecules like formaldehyde to find reactive sites. However, 
experiments with extended incubation times with higher concentrations were not 
performed, so it is not possible to assess the stability and homogeneity of the surface and 
their exposed amino groups in those cases.  
 
Second part: [14C]-Acetaldehyde radiolabeling of polysaccharide surfaces. 
As can be observed in Figure 7, in the first part of the surface modification GAGs are 
deposited by the well-known method of reductive methylation90, using cyanoborohydride, 
of the Schiff base produced in the reaction between the primary amine and the aldehyde. 
The secondary amines present in the GAGs may also react to form an enamine, thereby 
masking the true surface density. The process of deamination91 of N-deacetylated GAGs 
is necessary given that several acetamido groups are present in the GAG chains.  
                                                 
90 Jentoft, N.; Dearborn, D.G., Labeling of proteins by reductive methylation using sodium cyanoborohydride, J. Biol. 
Chem. 1979, 254, 4359-4365. 
91 Cif. note 66 supra. 
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As mentioned, N-deaminative cleavage of deacetylated polysaccharides cleaves the 
glycosaminoglycans at their N-acetyl-D-glucosamine or N-acetyl-D-galactosamine 
residues leaving only a disaccharide or a monosacharide attached to the surface92. 
Exploting the fact that the secondary amine can react with a ketone or aldehyde, a final 
reaction produces a 14C labeled enamine, using the same method described in the 
radiolabeling of APTES. The reaction conditions used for the deacetylation and 
deamination are the ones standard in the literature, with the only change made here of 
extending reaction times for the deamination up to 1 hour to ensure total reaction. It is a 
little more difficult to eliminate residual hydrazine when the reaction is performed on 
surfaces, and after several rinses with water deamination was performed for 1 hour, 
instead of 15’. 
 
The deamination process is also beneficial to help in the enamine formation, for two 
reasons. First, given the structural limitations of the GAG-APTES chain, formation of the 
enamine tautomeric group will be favoured (versus formation of the imine group) by 
using small aldehydes or ketones and minimizing steric hindrances93. 
                                                 
92 Shively, J.E.; Conrad, H.E. Formation of anhydrosugars in the chemical depolimerization of heparin. Biochemistry 
1976, 15, 3932-3942. 
93 The chemistry of enamines,  S.F. Dyke, Cambridge Univesity Press, 1973. 
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Figure 8. Simplified scheme of the procedures for [14C]-Acetaldehyde radiolabeling of polysaccharide surfaces. 
In A) APTES is first fixed to glass in ethanol forming an amino terminated layer that is further modified with different 
GAGs for 24 hours in the presence of cyanoborohydride (B). In C.1) deacetylation of GAG chains is performed by 
hydrozinolysis and in C.2) the deamination reaction is shown. Deamination at pH 1.5 is performed only for HS GAGs. 
The nitrosamine formed is then reverted to the secondary amine by denitrosation in a reaction overnight (D). Finally, 
in E), radiolabeling can be performed by enamine formation using [14C]-Acetaldehyde. 
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It has been shown that, in general, reaction yields are higher by using aldehydes and that 
in some reactions enamine does not form by using ketones. The rate of enamine 
formation essentially depends on two factors: the basicity of the amine and steric 
hydrances. These considerations favoured the use of the aldehydes. Secondary reactions 
like aminal formation were not within the scope of this study and were not analyzed, 
however aminals do not form in reactions involving non-cyclic amines.  
 
A secondary reaction involves the formation of a N-Nitrosamine in the secondary amine 
in Figure. 8C that is quantitatively reverted to the secondary amine by denitrosation of 
the N-nitrosamine with removal with a trap (sodium azide) of the nitrous acid produced 
in the denitrosation in the presence of a good nucleophile (thiourea) in highly acidic 
conditions94.  
 
Concentration of the reactants was in molar excess in several cases. Conrad and 
coworkers used the following values for their reactions: 300 μg GAG: 20 μl NH2-NH2 : 
0.2 mg NH2-NH2. H2SO4 which represents between 5 and 30 molar excess of GAG over 
hydrazyne sulfate when performing the reactions in closed reacti-vials in suspension. 
However, 20 μl of pure anhydrous hydrazyne does not yield the volume necessary to 
cover a glass slip. Thus, the reactions were designed in order to deposit 200 μl of total 
volume on the surfaces and the solution used contained the same ratios of NH2-NH2 and 
NH2-NH2. H2SO4 employed by Conrad.  
 
The benefit of using small molecules like acetaldehyde is to have easier access to reactive 
sites, an important factor given that the reaction is performed on a surface. In this case, 
azeotropic elimination of water is not possible but, given the small volumes and molar 
quantities of the species over the surface, it suffices to eliminate water using a dissecator 
containing P2O5 or any other strong dissecant. After reaction, samples are rinsed with 
                                                 
94 Williams, D.L.H. Quantitative Aspects of Nitrosamine Denitrosation, in Nitrosamines and Related N-Nitroso 
Compounds, Loeppky, R.N. and Michejda, C.J. Editors, ACS, Washington, 1994. 
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acetonitrile and blown with a nitrogen stream. To avoid moisture and possible 
reversibility of the reaction, samples were immediately immersed in scintillation liquid 
and its radioactivity measured. 
 
Surface coverage obtained for polysaccharide surfaces is shown in Table 7.  Essentially 
the results indicate that the ratio of deposited GAG per amino terminal present on the 
surface is low and that there are small differences between GAGs, with larger molecules 
like CSC having slightly higher surface densities.  
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Table 7.  Surface coverage by [14C]-Acetaldehyde radiolabeling of GAG. 15’ deposited APTES surfaces were 
used in all cases. 
 
 
GAG HS KS CSA CSC 
Surface density 
 (sites/ μm2) 
 
478.5 +/- 59.5 
 
766.4 +/- 142.5 
 
690.4 +/- 136.8 
 
1060.2 +/- 290.2 
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Given that denitrosation is a fully quantitative process, improvements in the values can 
be made in the reaction yields of enamine formation by a strong elimination of water 
during enamine formation. 
 
A secondary aspect of the reaction, shown in Figure 9A, is  the possibility of a competing 
process occurring by the reaction between excess primary amines on the APTES surface, 
previously unreacted with GAGs, and the acetaldehyde. This possibility is eliminated 
because the deamination also cleaves primary amines on the APTES molecules. The 
reason is that the primary step in the deamination reaction is the nitrosation of the 
enamine95, 
 
 RNH2  + HNO2 ? RNH2NO+ + OH- 
 
and continues in subsequent steps with final elimination of N2 and conversion of the 
alkane to an aldehyde eliminated in subsequent washes. As mentioned, the conditions for 
the production of other species are complex and include formation of NO and NO2.  As a 
result, the deamination process cleaves all NH2 groups that may remain on the surface 
and on the GAG chains or convert them into nitrosamines that are later eliminated with 
the denitrosation procedure. To test this assesment, APTES control surfaces were 
subjected to direct hydrozinolysis, deamination, denitrosation and radiolabeling and the 
levels of radioactivity were similar to control glass cover slips that did not have amines 
on their surfaces, in contrast to control APTES samples not subjected to hydrozinolysis 
and deamination that showed lowered levels of radioactivity after formation of the 
Schiff’s base, as shown in Fig. 9B. 
 
Levels of radioactivity shown in Table 8 indicate two things: first that hydrozynolysis 
treatment of an APTES surface effectively eliminates the amino groups from the surface 
                                                 
95 Horton, D.; Philips, K.D. The nitrous acid deamination of glycosides and acetates of 2-amino-2-deoxy-D-glucose 
Carbohydr. Res.1973, 30, 367-374. 
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(with levels on the order of clean glass samples) and thus no contribution from amino 
groups to the surface density of GAG can be expected. The second is that when APTES 
surfaces are not treated with hydrazyne, the reaction produces higher levels of 
radioactivity than in the case of no hydrozynolisis treatment but lower than those found 
in the experiment with formaldehyde. This means that, in the conditions of the reaction, 
formaldehyde is more effective in producing the Schiff base than acetaldehyde, as it 
could be expected.
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Figure 9. APTES control surfaces subjected to hydrozinolysis, deamination, denitrosation and radiolabeling (A) 
did not produce any labelled material due to the non reactivity of the silanol with the acetaldehyde. In contrast, direct 
reaction between the primary amine and the acetaldehyde could be done via reductive amination (B). 
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Table 8. Surface coverage by [14C]-Acetaldehyde radiolabeling of control APTES and glass surfaces. 15’ 
deposited APTES surfaces of 0.86mM concentration were used in all cases. 
 
 
Surface APTES (treatment) APTES (no treatment) Glass (no treatment) 
Surface density 
(sites/ μm2) 
 
  127.2 +/- 58.4 
 
   12477 +/- 549.7 
 
       36.9 +/- 7.3 
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4.3 Discussion of surface analysis by AFM and ellipsometry 
 
Surface modification and GAGs deposition. Silanization in ethanol was choosen because 
the same procedure in aqueous media yields low surface concentration of amines. The 
initial low concentration of APTES, 0.43 mM, during an incubation of 15 minutes 
produces a submonolayer of product, which is not very convenient. To assess what is the 
maximum concentration of APTES that can be used in the deposition process that 
provides consistent results, silanization was done with APTES concentrations of 0.43 
mM, 0.86 mM, 2.10 mM, 4.20 mM and 21.0 mM. Simultaneously, the effect of time on 
the deposition was analyzed by observing height changes of the deposited layer. Times 
varied from 15 minutes to 15 hours.  
 
To avoid high rates of APTES polymerization, the concentration of APTES needs to be 
kept at low levels. The reason is that APTES hydrolyzes in aqueous solution forming 
aggregates that are even visible at high concentrations. APTES aggregates are not 
observed over the glass or silicon surfaces at very low concentrations. APTES multilayer 
formation could result in undesirable aggregates and structures giving unreliable results 
in imaging or force measurements. The result would be that immobilization of 
biomolecules using silanes will see loss of activity because of the hydrolysis of the 
siloxane layers. This problem –the multilayer formation- disappears after APTES is 
reacted with the glycosaminoglycans, assuming that a homogenous deposition of the 
GAGs is achieved. Methods to avoid polymerization of silanes include curing96 to 
produce the cross-linking of non reacted silanol groups, but here no attempt was made for 
curing given the homogeneous thickness obtained and the shorter time span of 
incubation. 
 
 
                                                 
96 Moses, P.R.; Wier, L.M.; Lennox, J.C. Finklea, H.O.; Lenhard, J.R.; Murray, R.W. X-ray photoelectron 
spectroscopy of alkylaminesilanes bound to metal oxide electrodes,  Anal Chem 1978, 50, 576-585. 
 75
Ellipsometry measurements and silanization conditions.  Single wavelength null 
ellipsometry was used, as is common practice in investigation of biological materials. 
Ellipsometry measurements have been successful using deposited monolayers of silanes 
on silica surfaces, with the assumption that the monolayers are uniform and 
homogeneous97, 98. In general, data obtained by ellipsometry of the deposited layers 
should be consider relative thickness due to the difficulty in establishing the real 
refractive index of the films and under the assumption that kf is zero and that there is no 
light adsorption. This estimation of film thickness is then highly dependent on an 
appropriate choice of the refractive index of the material, especially in cases where nf and 
layer thickness are correlated. Even if the deposition is a monolayer of product, the fact is 
that ellipsometric measurements are averaged over the area of the laser beam ≈ 0.6 mm2. 
The thickness of the silane layer was calculated assuming a refractive index of 1.422, 
verified with an Abbe refractometer.  
 
Under equal conditions, a disordered structure gives lower refractive indexes, so to verify 
that changes in the index of refraction had little effect on the thickness, some 
measurements were performed at 1.440, 1.422 and 1.380, which are in the range of 
values for the refractive indexes of alkilamine silanes (around 1.46)99. For instance, the 
height for 0.86 mM depositions was 1.07 nm assuming a refractive index of 1.380, 1.04 
nm with 1.422 and 0.97 nm with 1.440, which means that even if the depositions are 
disordered, the measurements in the heights wouldn’t change appreciably. With respect 
to the GAGs, the index of refraction was measured with an Abbe refractometer at 
concentrations of 10mg/ml. Values obtained were 1.344 for HS and KS and 1.346 for 
CSA and CSC. At very diluted concentrations of 0.1 μg/ml the refractive index changed 
slightly to 1.335 in all cases, which is in practice the value for PBS.   
                                                 
97 Wasserman, S.R.; Tao, Y.T.; Whitesides, G.M. Structure and reactivity of alkylsiloxane monolayers formed by 
reaction of alkyltrichlorosilanes on silicon substrates Langmuir 1989, 5, 1074-1087 
98 Ulman, A. Introduction to Ultrathin Organic Films. Academic Press, San Diego, CA, 1991. 
99 CRC Handbook of Chemistry and Physics, 71st  Ed., CRC Press, Boca Raton, FL, 1990. 
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Table 9a shows APTES thicknesses obtained with variation of concentration and time. 
The thicknesses found are lower than the length of the fully extended molecule (~ 1.3 
nm) for the case of a monolayer, as expected, and in agreement with previous results for 
low concentrations and incubation times. Concentration and reaction times affected 
differently the thickness of the layers. On one side, the deposition of 15’ at 0.43 mM gave 
a submonolayer of product. On the other side, high concentrations of APTES (21.0 mM) 
were used for comparison purposes only, given the high degree of polymerization that 
produces stacks of visible APTES flocks. The conclusion is that the parameter to control 
is the time of incubation, unless high concentrations are used. The best conditions to 
obtain a uniform deposition of APTES were obtained with incubation times and 
concentrations of 15’ and 0.86mM or 0.43 mM and 1 hour, respectively.  
 
An additional possibility that was tested in order to obtain homogeneous depositions was 
to interrupt the incubation time to wash the surface with water, and then continue the 
incubation again without drying the sample. Two tests were done with 0.86 mM solutions 
with 15’ or 1 hour initial incubation times. After water rinses samples were incubated 
during another 15 hours. That resulted in a very similar height, 9.61 nm for the 15’ 
sample and 9.58 nm for the 1h sample.  
 
This similarity is in contrast with the case were no water rinses are done, where the 
differences in height are near 50% after the 15’ and 1 hour incubation times. This of 
course conforms to the known fact that excess water increases polymerization of silanes. 
This procedure can be used as an alternative method to produce consistent and uniform 
stacks of APTES layers. If the interest is in obtaining high surface coverage, this method 
has the drawback of producing lower concentrations of amino groups on the surface. 
 
Thickness and surface coverage. It has been already commented that the thickness of the 
layers of silanes depositions and the number of reactive NH2 groups present on the 
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surface have been quantified in previous experiments using different experimental 
conditions, with values of 0.5 nm for height and surface coverage of 1.3 NH2 groups per 
nm2 using a concentration of 2.15 mMol of APTES and incubation time of 3 hours in dry 
toluene. As indicated previously, an experimental surface coverage for APTES of 0.14 
amino terminals per nm2 was obtained and multilayer formation with increased 
concentration only slightly changes surface coverage. 
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Table 9a. Variation of ellipsometric thickness of APTES layers with concentration and time. 
 
 
Thickness of layers (nm) Times 
APTES concentration 15’ 1h 4h 15h 
0.43 mM 0.85 +/- 0.13 1.04 +/- 0.33 1.46 +/- 0.32 7.68 +/- 0.87 
0.86 mM 1.04 +/- 0.22 1.50 +/- 0.10 2.33 +/- 0.42 26.3 +/- 3.5 
2.10 mM 1.47 +/- 0.22 2.16 +/- 0.17 3.00 +/- 0.26 39.3 +/- 2.7 
4.20 mM 1.87 +/- 0.27 3.33 +/- 0.20 7.92 +/- 0.61 54.1 +/- 5.8 
21.0 mM 2.33 +/- 0.34 4.11 +/- 0.68 9.48 +/- 0.76 110.3 +/- 3.1 
 
 
 
Table 9b. Variation of ellipsometric thicknesses of GAGs layers in dry state. GAGs were deposited on APTES 
layers of 0.86mM concentration and 15’ incubation time. 
 
 
GAGs HS KS CSA CSC 
Thicknesses (nm) 1.54 +/- 0.21 2.18 +/- 0.44 2.20 +/- 0.46 2.41 +/- 0.25 
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Some theoretical considerations follow. The thickness of the deposition is highly 
dependent on the concentration, time and solvent used. A theoretical calculation using 
simple bond lengths shows that a monolayer of product will be around 0.9 nm height 
assuming all atoms oriented approximately normal to the surface. If there is any 
difference between the calculated and experimental values, it may be due to the fact that 
some APTES chains are not in a completely all-trans configuration. In some experiments 
it has been found that the alkyl chains are oriented approximately normal to the surface, 
giving a high density packed APTES100. However, some groups101 have reported that 
approximately 25% of chains may be oriented toward the surface. In this description, 
GAGs chains can be considered either horizontal or vertical (it is assumed that no 
molecule can attach at 45º and that no molecule will have kinks allowing being vertical 
and horizontal). 
 
Maximum distances of the link O-Si-O in the oxide layer are in the order of 0.4–0.5 Å, 
assuming a non-linear configuration. Ellipsometry measurements show that when having 
a monolayer of APTES the limiting factor in the increase of surface coverage of GAG is 
not the APTES surface coverage. Thus, it is not possible to assume, in first 
approximation, that in the reductive methylation via NaBH3CN all available APTES sites 
react with GAGs. Then it is possible to calculate the maximum GAGs chains that can be 
accommodated in this surface. Although our GAGs have not been crystallized and 
information of the crystal cell dimensions is not available, a rough estimate for the 
maximum and minimum dimensions can be made by using some available cell 
dimensions of similar sulfated monosaccharides. With the standard description of the cell 
parameters used in the literature, and assuming that around 75% of APTES chains do not 
bend towards the substrate, as indicated previously, cell dimensions for β-D-mannan are 
                                                 
100 Henke, L.; Piunno, P.A.E.; McClure, A.C.; Krull, U.J. Covalent immobilization of single-stranded DNA onto 
optical fibers using various linkers Analytica Chimica Acta, , 1997, 344, 201-213. 
101 Bergkvist, M., Carlsson, J. Karlsson, T. TM-AFM Threshold Analysis of Macromolecular Orientation: A Study of 
the Orientation of IgG and IgE on Mica Surfaces  J. Colloid Interface Sci. 1998, 206, 475-481. See also Xiao, Cif. note 
63 supra. 
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in the order of 8 Å102, which mean that each GAG chain will occupy the linear space of at 
least 2 silane groups. Cells with sulfate groups have bigger cell dimensions and, using 
data from X-ray structure analysis of an N-sulfated monosaccharide sugar103, it is 
estimated that each GAG chain could occupy the linear space of at least 4 silane groups. 
In other words, the upper limit for surface coverage for highly sulfated GAGs (HS or 
heparin) when covalently deposited on APTES may be around 1/4 of the experimentally 
found APTES surface density, while for less sulfated GAGs (chondroitins, KS) or non-
sulfated (hyaluronian) the upper limit may be one half. Steric effects between GAGs 
during incubation could produce additional reductions in these ratios but these have not 
been quantified. 
 
The results can be compared with some values calculated for the glycocalyx and for 
adsorbed molecules. With the distance between chains of 2–4 nm in the glycocalyx, the 
graft density for some GAGs chains in the glycocalyx can be at a maximum 0.25 
chains/nm2, which can be considered very high. In comparison, most common 
experimental depositions of adsorbed molecules are in the range of 0.001 to 0.05 
chains/nm2.  In this case, an experimental APTES surface coverage of 0.14 chains/nm2 
has been obtained. Assuming a reaction yield between GAGs and APTES of only 25%, 
then a reasonable expected surface coverage for GAGs will be for KS, CSA and CSC of 
~ 0.017 chains/nm2 and of ~ 0.008 chains/nm2 for HS.  
 
 
 
 
                                                 
102 Frei, E.; Preston, R.D. Non-Cellulosic Structural Polysaccharides in Algal Cell Walls. III. Mannan in Siphoneous 
Green Algae  Proc. Roy. Soc. (London), 1968, B169, 127-145. 
103 Ojala, W.H.; Albers, K.E.; Gleason, W.B.; Choo, C.G. Carbohydrates with relevance to the structure of 
glycosaminoglycans: the crystal structures of 2-deoxy-2-(sulfoamino)-α-D-glucopyranose sodium salt dihydrate, 2-
amino-2-deoxy-α,β-D-glucopyranose 3-(hydrogen sulfate) monohydrate and 2-amino-2-deoxy-α-D-glucopyranose 6-
(hydrogen sulfate) monohydrate,Carbohydrate Research, 1995, 275, 49-65. 
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Table 10.  Comparison between experimental and theoretical values of surface coverage for GAGs. Theoretical 
values are based in the experimental results of 0.14 sites/nm2 for APTES. 
 
 
GAG (sites/ μm2) HS KS CSA CSC 
Experimental 
Theoretical 
478.5 +/- 59.5 
8,800 
766.4  +/- 142.5 
17,500 
690.4 +/- 136.8 
17,500 
1060.2 +/- 290.2 
17,500 
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A comparison of results using the experimental values and the theoretical calculations 
using as a base the experimental results of APTES (0.14 sites/nm2) are shown in Table 
10. They are in a ratio varying from 1:25 to 1:15. It must be noted that the expected 
results have been calculated with figures for the size of the elementary monosaccharide 
as if all contiguous chains were packed as in a crystal giving a distorted, to the low end, 
view of the experimental results of the measured density of GAGs. 
 
As a conclusion, although the GAG surface density can be considered low, it has to be 
noted that full or highly packed surface coverage is not the situation in which cell surface 
recognition occurs and that our intention is replication of the glycocalyx density, not the 
maximization of surface coverage. 
 
AFM and ellipsometry thickness comparison. AFM images of chondroitin sulfate A  
patterned structures are shown in Figure 5. AFM images were obtained only for CSA, 
then the comparison will be given only for this GAG. Contour length, estimated 
molecular mass and number of charges per dimer in CSA are as follows: CSA (Lc =54 
nm, charges= 2, MM dimer = 456). Values of the molecular mass of the products were 
taken from the manufacturers. Classical estimates of level of sulfation given by 
Lindahl104, were used to calculate molecular mass of dimer.  
 
Using our results for 0.86mM APTES concentration and 15’ deposition time, table 9b 
shows the ellipsometric thicknesses obtained for the deposition of GAGs. This height is 
in dry state and gives an idea of how the total length of the extended molecule affects the 
process of laying down on the APTES surface. As it could have been expected 
intuitively, the longer the contour length, the higher is the average stack formed by the 
molecules. These dry brushes, of course, represent the incompressible layer of the 
polymer chains. Given that the thickness determination by ellipsometry is calculated over 
the area of the laser spot, which is around 0.6mm2, it is convenient to compare it with the 
                                                 
104 Cif. note 1 supra.  
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thickness calculated from AFM using the analysis of cross-sections for CSA. As shown 
in Fig. 5, heights for CSA gave a mean value of 2.05 +/- 0.58 nm, very close to the 
ellipsometer value of 2.20 +/- 0.46 nm.  
 
4.4 Results of experiments of the static adhesion of cancer cells 
 
Three cell  lines, three different conditions (non treated, cDNA transfected and heparin 
resuspended cells) and 6 different surfaces were used in the experiments. At least 9 
results were acquired for each combination of cell line/condition/surface for a total of 
more than 500 samples. The results of the experiments are essentially divided in three 
parts. In the first part, expression of heparanase in the cells is demonstrated using 
different methods. In the second part, Western Blots permit the identification of best 
transfection times. Results and discussion of the adhesion experiments are described later 
in a third part. 
 
4.4.1 Immunostaining and heparanase activity and determination of cDNA 
transfection conditions  
 
Presence of heparanase on the BT20, A431 and MCF7 cells was detected. Fig. 10 
demonstrates the presence of heparanase in all cells. Generally, endogenous levels of 
heparanase are low for immunostaining with non transfected cells, and the 
immunostaining experiments were performed with cDNA transfected cells. Low natural 
levels of heparanase and instability of the molecule do not simplify identification and 
work.  
 
It is of interest to compare the levels of heparanase of the three cell lines and then if a 
correlation between amounts of heparanase expressed by the cells and number of 
adherent cells could be established. A commercial presentation of the assay that monitors 
the degradation of heparan sulfate (Takara Miro Bio) was used. A standard curve was 
prepared for the assay fitted to a sigmoid with 4-parameters, as recommended by the 
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manufacturer. 
 
The assay monitors the relative amount of enzymatically active heparanase, and as 
mentioned earlier, the adhesion assays were performed at physiological pH in order to 
analyze the involvement of inactive heparanase on the adhesion. As mentioned by 
Ihrcke105, inactivation of heparanase is due to a change in conformational state. It is 
possible that such conformational state changes during the lysis of the cells during the 
assay. It is assumed that the activity, as measured with this method, and the amount of 
heparanase have linear proportionality. Thus, levels of heparanase activity could provide 
only a partial indication of the involvement of heparanase in the adhesion when assessing 
whether higher amounts of heparanase in one cell line are correlated with increased 
adhesion levels. The reason is that part of the secreted heparanase binds to the cell 
surface, and part is released to the media. However, the exact mechanism of surface 
expression is not known. Recently, a model for heparanase biosynthesis was proposed106 
where endogenous heparanase is secreted and interacts with cell surface heparan sulfate 
proteoglycans (syndecan). A possible explanation of the activation of the hpa1 latent in 
cells was given by Fairbanks107. 
                                                 
105 Cif. note 35 supra. 
106 Cif. Note 75 supra. 
107 Fairbanks, M.B.; Mildner, A.M.; Leone, J.W.; Cavey, G.S.; Mathews, W.R.; Drong R.F.; Slightom, J.L.; 
Bienkowski, M.J.; Smith, C.W.; Bannow, C.A.; Heinrikson, R.L.  Processing of the human heparanase precursor and 
evidence that the active enzyme is a heterodimer. J. Biol. Chem.  1999, 274, 29587-29590. 
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Fig 10. Immunohystochemical localization of heparanase in A431 (A), BT20 (B) and MCD7 (C) cDNA 
transiently transfected cells. Identification was performed as described in the Experimental Procedures. Cell surface 
expression of heparanase in transfected cells was determined by indirect immunocytochemistry as described108 with 
modifications. Cells were first fixed with 3.7% paraformaldehyde for 30’ and later incubated with BSA 2% as blocking 
agent for another 30’. Cells were then incubated overnight at 4ºC with goat,  anti-human Heparanase 1 HPA1 (C20), 
polyclonal antibody (Santa Cruz Biotechnology, California) diluted 1:50 in PBS and then rinsed with PBS, followed 
by incubation (1:500 dilution) for 45 minutes at room temperature with horseradish peroxidase-conjugated secondary 
antigoat antibody  (Jackson Immunoresearch). Color was developed using EAC substrate (Lab Vision Corp. 
California), followed by counter-staining with Mayer’s hematoxylin. Cells were visualized (micrographs 
amplifications are 40X in all cases) using bright field light microscopy with a Leica DMLB microscope and 
photographed with a Diagnostic Instruments RT color camera. Controls for negative expression were taken without 
addition of primary antibody. 
                                                 
108 Cif. note 5, supra.. 
A B
C
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Fig.11 Heparanase activity and Western Blots. Levels of heparanase activity (in arbitrary units per ml) of BT20, 
A431 and MCF7 non treated cells (top) and blots identifying best cDNA transfection times (bottom).  Selected 
transfection times were 36h for MCF7 cells and 24h for BT20 and A431 cells, as described in Experimental Procedures 
section. 
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4.4.2 Static cell adhesion to the different substrates 
 
To address the question of how the adhesion of cells differs for different GAGs, adhesion 
experiments were performed in which cells were seeded on glass cover slips 
functionalized with GAGs and the number of cells attached were counted after a 
specified period of time. Glass cover slips were coated with a monolayer of APTES over 
which covalently attached monolayers of GAGs were deposited with the technique 
described in previous sections.  
 
Results are first presented independently for each cell line and later a comparison is made 
for all cell lines. For each cell line, results are presented for each different condition 
tested during the adhesion experiments. The following considerations should be noted: 
 
a) Adhesion information is broken-down into two parts, control surfaces and GAG 
substrates. The reason is that GAG substrates figures must be normalized to 
equivalent surface densities, to make the analysis meaningful. All calculations were 
adjusted to the CSC surface density. (See Table 7). 
b) Given that there are three different experimental conditions, further analysis will be 
performed by presenting GAG adhesion information relative to non-treated cells.  
c) In all cases, the number of cells seeded was 2.5 x105 on the cover slips. 
 
Results for MCF7 cells. 
Figure 12 represents absolute number of cells attached (in cells per ml) to the four 
different GAG substrates, adjusted for surface densities of GAGs. The main observations 
are: 
 
1) Non-treated MCF7 cells attach in higher numbers to HS and CSA but not to CSC and 
KS substrates. Globally, HS appears to be a preferred substrate for adhesion. 
2) Taking each substrate individually, and for all substrates, the number of adherent 
cells follows the decreasing sequence: non-treated – cDNA – heparin suspended.  
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3) Heparin suspended cells decreased adhesion with respect to untreated cells and 
cDNA transfected cells up to 250%.  
 
Figure 13 shows the relative percentage of cells cDNA transfected or heparin suspended 
with respect to non-treated cells, for the four different GAG substrates, adjusted for 
surface densities.  
 
The main observations are: 
1) Compared to non-treated cells, MCF7 cDNA transfected cells show a 50% increase in 
adhesion to CSC and KS, and a reduction in adhesion around 50% for CSA and HS. 
2) Compared to non-treated cells, MCF7 heparin suspended cells show about 60-70% 
decrease in adhesion, except for CSC, only 25%. 
 
Results for A431 cells. 
Figure 14 represents the absolute number of cells attached (in cells per ml) to the four 
different GAG substrates, adjusted for surface densities. The main observations are: 
 
1) Non-treated A431 cells attach in higher numbers to HS and CSA but not CSC and KS 
substrates. Globally, HS appears to be a preferred substrate for adhesion, as in the 
case of MCF7 cells. 
2) Taking each substrate individually, and for all substrates, the number of adherent 
cells follows the decreasing sequence: non-treated – cDNA – heparin suspended, 
except for KS. 
3) Heparin suspended cells decrease adhesion with respect to untreated cells and cDNA 
transfected cells except for KS. This reduction is less dramatic than in MCF7 cells.  
 
Figure 15 shows the relative percentage of cells cDNA transfected or heparin suspended 
with respect to non-treated cells, for the four different GAG substrates, adjusted for 
surface densities.  
The main observations are: 
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1) Compared to non-treated cells, A431 cDNA transfected cells show small increases in 
adhesion to HS and CSA and no changes in adhesion for CSC and KS. 
2) Compared to non-treated cells, A431 heparin suspended cells show about 20-50% 
reduction in adhesion, except for KS, that shows 25% increase. 
 
Results for BT20 cells. 
Figure 16 represents the absolute number of cells attached (in cells per ml) to the four 
different GAG substrates, adjusted for surface densities. The main observations are: 
 
1) BT20 cells show strong preference for HS substrates and low preference for KS, as 
with the other two cell lines, for all conditions. 
2) Heparin suspended cells reduction in adhesion respect to untreated cells is small in all 
cases. 
3) Cells do not change adhesion to CSA or CSC substrates. 
 
Figure 17 shows the relative percentage of cells cDNA transfected or heparin suspended 
with respect to non-treated cells, for the four different GAG substrates, adjusted for 
surface densities.  
 
The main observations are: 
3) Compared to non-treated cells, BT20 cDNA transfected cells show almost 50% 
increase in adhesion to CSA and KS, and a reduction in adhesion around 50% for HS. 
4) Compared to non treated cells, BT20 heparin suspended cells show about 30-40% 
reduction in adhesion, except for CSA, with an increase of 25%. 
 
Comparison of all cells. 
Figure 18, 19 and 20 show a comparison of absolute number of cells attached (in cells per 
ml) to the four different GAG substrates, adjusted for surface densities, for the three cell 
lines, for non treated, heparin resuspended and cDNA transfected cells, respectively.  
a) For untreated cells (Figure 18): 
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a.1) HS is the preferred substrates for all cells. 
a.2) All cells attach similarly to KS and CSC. 
a.3) KS is not a preferred substrate for attachment for any cell line. 
b) For heparin suspended cells (Figure 19): 
b.1) MCF7 cells are substantially more affected by suspension in heparin than the 
other two cell lines and show decreased levels of adhesion to all substrates. 
b.2) Heparin increases substantially the adhesion of A431 cells to KS and BT20 to 
HS, compared to the other two cell lines. 
b.3) BT20 cells show preferred adhesion to HS even after suspension in heparin. 
c) For cDNA transfected cells (Figure 20): 
a.1) As with heparin, MCF7 cells attach in lower or equal number to all substrates, 
except KS. 
a.2) All cells attach similarly to CSC. 
a.3) All cells continue showing preferred adhesion to HS. 
 
Comparison of all cells with glass and APTES substrates. 
Figures 21, 22 and 23 show a comparison of absolute number of cells attached (in cells 
per ml) to glass and APTES, for the three cell lines, for non treated, heparin resuspended 
and cDNA transfected cells, respectively. 
 
a) For untreated cells, glass is a similar substrate, but APTES shows substantial 
differences between cell lines, with A431 strongly adhering and BT20 not. 
b) For heparin suspended and cDNA transfected cells lower adhesion is observed for all 
cell lines compared to glass and a similar pattern of increased adhesion going from 
MCF7 to A431 cells. 
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Fig.12. Absolute adhesion of MCF7 cells. Absolute number of MCF7 cells adhered to the specified substrates after 8 
hours of incubation time. The three different conditions tested –non treated, heparin resuspended and cDNA 
transfected cells- are shown.  
 
 
 
 
 
 
 
 
 
 
 
Fig.13. Adhesion of MCF7 cells relative to non-treated cells. Cells adhered to the specified substrates after 8 hours 
of incubation time, compared to untreated cells. Heparin resuspended and cDNA transfected cells percentages are 
shown. 
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Fig.14 Absolute adhesion of A431 cells. Absolute number of A431 cells adhered to the specified substrates after 2 
hours of incubation time. The three different conditions tested –non treated, heparin resuspended and cDNA 
transfected cells- are shown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.15. Adhesion of A431 cells relative to non-treated cells. A431 cells adhered to the specified substrates after 2 
hours of incubation time, compared to untreated cells. Heparin resuspended and cDNA transfected cells percentages 
are shown. 
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Fig.16 Absolute adhesion of BT20 cells. Absolute number of BT20 cells adhered to the specified substrates after 2 
hours of incubation time. The three different conditions tested –non treated, heparin resuspended and cDNA 
transfected cells- are shown. 
 
Fig.17. Adhesion of BT20 cells relative to non-treated cells. BT20 cells adhered to the specified substrates after 2 
hours of incubation time, compared to untreated cells. Heparin resuspended and cDNA transfected cells percentages 
are shown. 
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Fig.18. Comparison of adhesion of MCF7, BT20 and A431 non-treated cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.19. Comparison of adhesion of MCF7, BT20 and A431 heparin resuspended cells. 
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Fig.20. Comparison of adhesion of MCF7, BT20 and A431 cDNA transfected cells. 
 
 
 
 
 
 
 
 
 
 
Fig.21.  Absolute number of MCF7, BT20 and A431 non-treated cells adhered to glass and APTES. 
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Fig.22.  Absolute number of MCF7, BT20 and A431 heparin suspended cells adhered to glass and APTES. 
 
 
 
 
 
 
 
 
 
 
Fig.23.  Absolute number of MCF7, BT20 and A431 cDNA transfected cells adhered to glass and APTES. 
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Discussion. Cell adhesion requires ligand-receptor interaction. A full description of the 
adhesion at the molecular level requires information of the substrates (that are known in 
this study) and possible adhesion receptors on the cell surface. Several molecules bind to 
heparan sulfate (and possibly to other glycosaminoglycans) in a list that include 
chemokines, FGF, integrins and the selectin family, but in this work the focus is not in 
the elucidation of the precise mechanism used by each cell line, althought some insights 
are given. To simplify the discussion, the following assumptions and clarification are 
made. Even after, some complexity in the analysis will remain given that the work has 
been performed with three cell lines with three conditions and six surfaces:  
 
1) It is clear that the type of adhesion performed here corresponds to firm, permanent, 
static adhesion. Then, the first assumption is to discard the possibility that the 
adhesion is mainly due to the involvement of the abundant set of molecules 
participating in transient adhesion, that are well known in transient leukocyte and 
cancer cell adhesion to the endothelium: that includes sLex and sLea binding to E- and 
P-selectins and L-selectin binding to sialylated or sulfated glycans. 
2) It is known that glycosaminoglycans may bind, electrostatically, to other 
polysaccharides. However, a second assumption will be that cell surface 
glycosaminoglycans will not be involved in the adhesion to GAGs substrates. That is, 
it is assumed that receptors and substrates have different chemical and functional 
compositions. 
3) Introducing heparanase-inhibiting molecules in cell cultures to analyze any reduction 
in the binding processes was performed by resuspension of the cells in heparin for 
30’. In addition, in some instances where cells have been transfected with 
heparanase109, heparin enhances accumulation of heparanase in cell culture medium, 
but there is no information at what rate. Values provided by these authors are for 24 
hours, not thirty minutes nor during the time the cells are adhering (two hours or eight 
                                                 
109 Cif. note 75 supra. 
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hours). Thus, it is assumed that resuspension in heparin will have little impact on the 
accumulation of heparanase on the media or on its distribution on the cell surface, 
and that its regular trafficking is not substantially affected during this time.  
4) Also, it is emphasized that incubation temperature was 37ºC and pH in physiological 
conditions. This situation ensured that heparanase was not enzymatically active but 
could bind or mediate binding to the ligands on the substrates and also to heparin 
present in the medium during resuspension. 
 
4.4.3 Discussion of adhesion by cell line 
 
MCF7. MCF7 cells attach in substantially higher numbers when cells are non-treated to 
HS and CSA. In general the effect of heparin is more intense than with the other cell 
lines. Because transfection of the cells and resuspension in heparin was not performed 
simultaneously, it is not possible to claim that transfection had the net effect of 
overcoming, albeit partially, the reduction in the adhesion in the presence of heparin. 
However, for two substrates the adhesion with cDNA transfected cells is higher than with 
non treated cells. This result, along with the result that HS is a strongly preferred 
substrate for adhesion in all cases, provides strong indication that MCF7 cells use 
heparanase –preferentially or as a mediator or secondary adhesive mechanism- in their 
binding to glycosaminoglycans. The increased adhesion to CSC after transfection may be 
due to the ability of the cell to find appropriate attachment sites with extended, longer 
molecules. 
 
In all cases, MCF7 cells resuspended in heparin containing media show decreased 
adhesion with respect to untreated cells. Except for the case of CSC, this decrease is 
around 50%. There are two reasons that may explain this behaviour. If the adhesion is 
mediated by heparanase, then the reduction could be explained mainly by heparin 
blocking heparanase. If the adhesion is due to other molecules, then those molecules are 
effectively affected by heparin in the media, with the net effect of reducing the adhesion. 
This effect is clearly shown in the cases of CSC and KS. However, the results for HS and 
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CSA remain to be explained, because after cDNA transfection an increase should be 
expected.  
 
Of special interest is the additional observation that the number of adherent cells in 
heparing containing media does not vary substantially between different substrates. This 
indicates that cells are probably using more than one mechanism for adhesion, and that a 
secondary mechanism blocked by heparin is the same for all surfaces. The mechanism 
could be heparin blocking integrin chains110,111.  Heparin has been shown to block P-
selectin mediated adhesion of tumor cells to endothelial cells. But, as mentioned before, 
mechanisms involving P-selectins, receptors that are known to bind glycosaminoglycans 
and that are found in MCF7 cells, are discarded here because they are associated to 
transient adhesion.  
 
A431. Apart of the high natural expression of heparanase in these cells, other receptors 
that are known to bind glycosaminoglycans are found in A431 cells112. There is moderate 
expression of sLex and sLea. On the other side A431 cells strongly express ß1, α3, α6, 
and αv and moderately express α2 and α5 integrin chains with no significant expression 
of α4 and α1 integrins. 
 
Generally, A431 show similarities with MCF7 cells for cells suspended in heparin 
containing media, showing decreased adhesion respect to untreated cells. Also, the 
substrate with the highest binding of cells is HS, again in support of the heparanase 
mediated adhesion. In contrast to MCF7 cells, where almost all substrates showed deep 
                                                 
110 Sobel M, Fish WR, Toma N, Luo S, Bird K, Mori K, Kusumoto S, Blystone SD, Suda Y. Heparin modulates 
integrin function in human platelets. J Vasc Surg. 2001, 33, 587-94. 
111 Brockbank, E.C.; Bridges, J.; Marshall, C.J.; Sahai, E. Integrin beta1 is required for the invasive behaviour but not 
proliferation of squamous cell carcinoma cells in vivo. British Journal of Cancer. 2005, 92, 102-112. 
112 Tei, K.; Kawakami-Kimura, N.; Taguchi, O.;  Kumamoto, K.;  Higashiyama, S.; Taniguchi, T.; Toda, K.; Kawata, 
R.; Hisa, Y.; Kannagi, R. Roles of Cell Adhesion Molecules in Tumor Angiogenesis Induced by Cotransplantation of 
Cancer and Endothelial Cells to Nude Rats. Cancer Research. 2002, 62, 6289-6296. 
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reduction in adhesion for heparin suspended and cDNA transfected cells, A431 cells 
show small increases, no change or small reduction in almost all substrates respect 
untreated cells. This smaller reduction in the adhesion when cells are resuspended in 
heparin medium may be due to the different levels of heparanase activity in the cells -
much higher in A431 and then the same concentration of heparin leaves unblocked more 
heparanase that can be used for adhesion to the substrates-.  
 
BT20. Two main aspects can be mentioned about the adhesion of this cells. First, again 
indicating heparanase involvement in the adhesion, cells strongly attach to HS substrates 
with numbers higher than in the other cell lines.  The adhesion to KS and CSC follow the 
same patterns of the other two cell lines, with low adhesion levels. It is interesting to note 
that in this cell line, except in HS, cDNA transfected cells show the highest attachment.  
 
4.4.4 Comments of the adhesion of cells by the origin of the cell line 
 
It is of interest now to try to relate the observed preferences for adhesion of the cell lines 
with the substrates and some basic aspects of tumor origin and tissue distribution of the 
glycosaminoglycans, with the reminder that experiments here were performed in vitro.  
It is of course highly unlikely that the adhesion results obtained here can be of any direct 
application to the complex analysis of in vivo metastases. But at least it would be 
interesting to answer the question if it is possible to obtain a basic link between 
preferential adhesion of the cells (in vitro) to GAG substrates and the experimental 
metastases observed for these cell lines. In addition, could these results be indicative of 
preferential locations for metastasis after a hypothetical treatment with heparin or when 
cells overexpress heparanase?. 
 
After adjusting for equal surface density of GAGs and, excluding the values for control 
substrates (glass and APTES), non treated cells showed preferential adhesion to heparan 
sulfate substrates in all cell lines. All cells show CSA as secondary preference (with two 
exceptions). HS is present in several tissues and organs, mainly in lung, liver, arterial 
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wall and in several cell surfaces. As expected, the affinity of the cells for HS chains 
shown here implies that this type of adhesion could prove helpful for the cells during 
metastasis. 
 
Heparin suspended cells show preferential adhesion to HS for MCF7 and BT20 and to 
CSA for A431 cells. CSA is mainly present in cartilage, bone and skin. This results may 
indicate that it may prove more difficult to reduce metastases of MCF7 and BT20 cells 
using heparin than to do it with A431 because they seem to have higher affinity for HS 
susbtrates after heparin resuspension –assuming that the cells use binding to HS chains at 
some point when their tumors metastasize-. Also, given that A431 shows preferential 
adhesion for CSA after resuspension it would be possible to observe a tendency for A431 
cells to metastasize to tissues with abundant CSA content. cDNA transfected cells 
showed preferential adhesion to HS for BT20 and A431 cells and KS for MCF7 cells. 
This may indicate preferential locations for metastasis for these cell lines.
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Table 11.  Preferred substrates for adhesion of cancer cells. The preferred and secondary GAG substrate for in vitro 
adhesion of MCF7, A431 and BT20 cells under three different conditions. Preferences are equal for all cell lines 
(preferred:secondary ? HS:CSA) except for the two exceptions noted. 
 
 
Cell line MCF7  
Breast carcinoma 
BT20 
Breast carcinoma 
A431 
Epidermoid 
 
Preferred 
adhesion 
HS HS HS  
 
Non treated cells 
 
Secondary 
adhesion 
CSA CSC-CSA* CSA 
Preferred 
adhesion 
HS HS CSA  
Heparin 
suspended cells Secondary 
adhesion 
CSC-CSA* CSA KS 
Preferred 
adhesion 
HS HS HS  
cDNA 
transfected cells Secondary 
adhesion 
CSC CSA CSA 
* close results 
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4.4.5 Discussion of adhesion by type of substrate or surface 
 
KS surfaces: Low adhesion to KS in all conditions and for all cell lines is a very broad 
result. In all cases, -non transfected cells, with heparin or for cDNA transfection- cells 
show little affinity for attachement to KS, with the exception of A431 cells in heparin and 
the more moderate attachment of cDNA transfected cells. This anti-adhesive property of 
KS has been observed and established previously113,114. The confirmation of this observed 
property in the experiments conducted here provides good support for the quality of the 
techniques used in this project. Levels of adhesion to KS substrates are very similar in all 
cases, except for A431 heparin suspended cells; a result not too surprising given that 
A431 heparin suspended cells show similar levels of adhesion to all substrates, in 
contrast with the other two cell lines. 
 
A possible explanation of the lack of adhesion between the cell lines tested and the 
surfaces with KS would be to assume that the adhesion of the tumor cells is mediated by 
selectin receptors. In this case, E-selectin would try to find syalyl Lewis x antigens whose 
main structural difference with KS is that they are fucosylated on the glucosamine near 
the nonreducing terminus of the molecule. These types of glycosaminoglycan forms are 
present on endothelial cells and serve as selectin receptors. 
However, as was mentioned in the introduction of this section, selectin mediated 
adhesion is due to transient adhesion and it was assumed not to be the type of adhesion 
under consideration. As it will shown later, the reasons for the low level of adhesion are 
related to dimer charge, sulfation levels and chain length. 
 
 
 
                                                 
113 Funderburgh, J.L.; Mitschler, R.R., Funderburgh, M.L; Roth, M.R.; Chapes, S.K.; Konrad, G.W. Macrofage 
receptors for lumican, a corneal keratan sulfate proteoglycan. Invest. Ophthalmol Vis. Sci. 1997, 38, 1159-1167. 
114 Burg M.A.; Cole G.J. Claustrin, an anti-adhesive neural keratan sulfate proteoglycan, is structurally related to 
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HS surfaces: Apart of the enzymatic activity of heparanase on heparan sulfate chains 
(cleavage in the ECM or cell surface), Goldshmidt115 has proposed that heparanase-
mediated cell adhesion most likely could involve heparan sulfate chains.  However, in 
one experiment, removing 85% of all ECM sulfated material from endothelial cells did 
not affect adhesion. The results of that work suggest that heparanase mediated cell 
adhesion could happen due to the effect of net cell surface charge after interaction with 
HS, but not necessarily by binding with HS.  
 
As has been mentioned before116, the current understanding of heparanase trafficking 
includes a step in which secreted heparanase is sequestered by cell surface proteoglycans 
by binding to their heparan sulfate chains. The presence of heparin in the medium 
increases accumulation of heparanase in the culture medium after several hours, and the 
process competes with heparanase binding to HS chains. Here, experiments were 
performed with heparin resuspension time of 30’ and adhesion times of two hours and 
eight hours. Then, it is unclear how much competition heparin could have and levels of 
heparanase on the cell surface should not be affected. 
 
The previous discussion indicates that secreted heparanase is able to bind HS chains on 
the cell surface, and then it is highly presumable that it also could do so to HS substrates. 
This is very clear, and a general result of the experiments. The precise interaction of 
heparanase binding to heparin is unknown, but O-sulfation of heparin chains is not 
necessary, while N-sulfation is.  
 
It is now possible to analyze cell attachment to HS substrates in light of the previous 
discussion. As it can be observed in Figure 18, HS can be considered a good substrate for 
the adhesion of non-treated cells, in all cell lines. This result is likely to be related to the 
                                                                                                                                                 
MAP1B. J. Neurobiol. 1994, 25, 1-22. 
115 Cif. note 36 supra. 
116 Cif. note 75 supra. 
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total electronic charge present in the molecule, an aspect that will be discussed later.  
Figure 19 shows a reduction in adhesion for MCF7 and A431 cells with heparin, but the 
decrease is similar for all substrates (except for BT20 cells). That shows that heparin is 
biding to heparanase on the cell surface. The differences between cell lines and substrates 
in the level of reduction is due to the different levels of heparanase expressed and how 
other mechanisms participating in the adhesion are affected.   
 
Chondroitin surfaces: Chondroitins used in the experiments differ essentially in two 
aspects: chain length and structural sulfation. They are similar in number of charges and 
sulfation groups per dimer. CSA contains approximately 90% of its approximately 54 
dimers with 4-sulfated groups, while CSC has its approximately 131 dimers with 90% 6-
sulfated groups. The possible relation with chain length and sulfation level and structure 
is analysed in a later section. As it can be seen in the results, CSA and CSC are the 
surfaces least affected by the presence of heparin in the media or by increased heparanase 
on the cell surface. There is another trend in this adhesion. MCF7 cells attach in lower 
numbers than BT20, and BT20 cells less than A431, or at the same level. This tendency 
is observed for all conditions in both substrates, with the exception of non treated MCF7 
cells. Chondroitins are not know for their anti-adhesive properties, like KS. But their 
small changes in adhesion with these cells in the experimental conditions used are in line 
with the lack of information regarding heparanase binding to chondroitins. In particular, 
CSC, a long molecule with mainly 6-sulfate groups seems particularly unaffected by the 
conditions. 
 
Glass. Clean glass surfaces offer a monolayer of hydroxyl groups surrounded by water 
molecules on top of the silicon substrate that provides a neutral or slightly negatively 
charged surface. The main difference between glass and APTES surfaces and the rest of 
the substrates is that in glass and APTES adhesion is non specific and in absolute terms 
adhesion can be higher. This is shown in Figure 21 for non transfected cells, where 
MCF7 and BT20 cells show the highest levels of adhesion and high, but not the highest 
for A431 cells. It is interesting to note that heparin reduces adhesion essentially to 
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APTES surfaces (see next paragraph) but not (except for MCF7) to glass. This is clearly 
due to the opposite charge on the surfaces. 
 
APTES. APTES surfaces provide a highly positively charged surface. Althought it is 
known that cells can attach to positively charged surfaces, the type of attachment here is 
by non-specific adsorption. Given that cells are cultured in regular media and deposited 
resuspended on it, calcium and magnesium are present and electrostatic repulsions 
between surface and charges in the medium present a barrier for adhesion.  
 
For non-treated cells, adhesion to APTES is low for MCF7 cells, the lowest for BT20 
cells and the highest for A431 cells as shown in Figure 21. Assuming that the adhesion is 
electrostatically affected or mediated, Figure 22 shows that the the net effect of heparin is 
to block domains or regions having negatively charged groups, with significant reduction 
levels in MCF7 and A431, and a small increase in BT20.  
 
Increased presence of heparanase also continues with this trend. As it has been 
mentioned, heparanase binding to proteoglycans on the cell surface may block exposure 
of other negatively charged domains and the reduction is more pronounced in MCF7 and 
A431 cells, as shown in Figure 22. 
 
4.4.6 Discussion of adhesion by the molecules involved. Heparin and heparanase 
effects on adhesion 
 
1. Heparin had the effect of reducing the adhesion of the cells to all substrates and all 
cell lines respect to the levels of non-treated cells, with the exception of KS for A431 
cells and CSA and APTES for BT20 cells.  
 
In the case of the MCF7 cell line, the reduction is similar to all substrates, indicating that 
the methods used by the molecule to block adhesion are virtually substrate independent, 
but this is not the case of the two other cell lines. The reduction in adhesion when heparin 
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is used is increasingly less intense in BT20 cells and A431 cells, in that order. Given that 
heparin binds to heparanase and that the level of heparanase activity in regular cells 
(Figure 11) in these three cell lines are inversely proportional to the reduction caused by 
heparin, the results provide indication that heparanase is participating in the adhesion.  
 
But because heparin also binds several other molecules in the cell surface, including 
integrins, the only conclusive assertion that can be made is that these experiments 
provide additional evidence that heparin blocks the observed adhesion and that the 
reduction is cell dependent. 
 
As has been mentioned before, in the theoretical introduction of this document, heparin 
has reached the phase of use in clinical trials because it has been shown to reduce the 
incidence of metastasis. The anti-metastatic activity of heparin has two sides: by 
reduction of P-selectin adhesion117,118 and by inactivation of heparanase activity, that has 
the effect of preventing degradation of the ECM by heparanase secreted by the cancer 
cells.  
 
However, the effect of heparin on the adhesive properties of heparanase is unclear. The 
results of the adhesion experiments shown here, albeit non conclusive respect to this role, 
are in the trend of previous works119,120 indicating that heparanase activity inhibitors 
failed to affect adhesion of cells to the vascular endothelium. The main reason for which 
it is unclear is because the expression of heparanase on the cell surface is not completely 
understood, seems to be cell line dependent with only 25% of the total heparanase 
secreted in the cell bound to the surface. Heparanase in the media is uptaken by heparin, 
but it is not clear if heparin will bind heparanase already bound to HS chains in the cell 
                                                 
117 Stevenson, J.L.; Choi, S.H.; Varki, A. Differential metastasis inhibition by clinically relevant levels of heparins--
correlation with selectin inhibition, not antithrombotic activity. Clin Cancer Res. 2005, 11, 7003-7011. 
118 Cif. note 79, supra. 
119 Cif. note 5, supra. 
120 Cif note 32 supra. 
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surface. The exact chain location of the binding between heparanase and 
glycosaminoglycans is not known and it is highly unlikely that heparanase can work as a 
multivalent molecule.  
 
 
2. cDNA transfected cells showed mixed results in adhesion reduction or adhesion 
increase with respect to non-treated cells.  
 
The cell line with the lowest level of heparanase activity in regular cells –MCF7- shows 
substantial reduction in the level of adhesion to all substrates, except to CSC and KS, and 
the reduction in the adhesion is close, but lower, than when heparin was used. On the 
other side, the cell line expressing the highest level of heparanase activity, A431, shows 
similar or increased levels of adhesion to the substrates respect non-treated cells and the 
same is found with the other cell line BT20. As mentioned before, the expression of 
heparanase on the cell surface seems to be cell dependent and it is not known in the case 
of these cell lines. Moreover, the differential expression of the enzyme on the cell surface 
after cDNA transfection is not known. These mixed results show that heparanase 
overexpression only partially enhances cell adhesion respect to non-treated cells, and 
that, depending on the cell line and substrate, heparanase overexpression actually reduces 
cell adhesion.  
 
4.4.7 Discussion  of the adhesion as a function of polysaccharide charge and chain 
length 
 
Three important aspects were mentioned in the introductory part of this document that 
prompt for cell adhesion analysis under a perspective that differs from what has been 
written in this document so far. It is of high interest to determine if adhesion levels of the 
cells have some type of underlying functional dependence on some of the physical and 
chemical properties characterizing glycosaminoglycans. Essentially, the analysis that 
follows will focus on the electronic charge per dimer of glycosaminoglycan and its chain 
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length, measured using the number of dimers that constitute the polysaccharide 
backbone.  
 
It has been known for some time that charge interaction between glycosaminoglycans 
and proteins may require conformational changes in proteins, and that these interactions 
increase with the length and charge density of the molecules121,122. It is also known that if 
L-iduronic acid is present, the binding has higher affinity than when it is not present.  
Thus, the results presented here give indication that cancer cells may have a functional 
dependence of their adhesion with the number of charges per dimer of the polyelectrolyte 
to which they are attaching and that this dependence takes the form of a linear function 
that increases with the number of charges of the dimer.  
 
Specific parameters of this linear function appear to be cell line dependent and are 
probably modulated by factors related to cell surface density of ligands. In addition, as a 
secondary hypothesis, a more subtle relationship between cell adhesion and length of the 
polysaccharide chain may exist, but this relationship is not as clear as the previous one. A 
third aspect included in this analysis is how the presence or absence of glucuronic acid 
and the sulfation of  the glucosamine residue affect adhesion levels and is implicitly 
included in central hypothesis presented here.  
 
The hypothesis then can be rewritten in the following form: for a fixed density of cell 
surface receptors that bind to glycosaminoglycans and a fixed density of  GAG ligands, 
cell adhesion to the polysaccharides is linearly dependent on the number of charges per 
dissacharide in the chain and also dependent on the length of the chain.  
 
For the analysis, the number of disaccharides (dimers) and charges per dimer of GAGs 
                                                 
121 Gelman, R. A.; Blackwell, J. Interactions between mucopolysaccharides and cationic polypeptides in aqueous 
solution: Chondroitin 4-sulfate and dermatan sulfate. Biopolymers, 1973, 12, 1959-1974. 
122 Gelman, R. A.; Blackwell, J. Interactions between mucopolysaccharides and cationic polypeptides in aqueous 
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are as follows: HS (dimers =22, charges=2.5, sulfate groups= 1.5) ; KS (dimers =32, 
charges=0.5, sulfate groups=0.5); CSA (dimers =54, charges= 2.0, sulfate groups=1); 
CSC (dimers =131, charges=1.75, sulfate groups=0.75). For this calculation, as it was 
done for the average molecular masses of the dimers, classical estimates of levels of 
sulfation given by Lindahl123 have been used.  
 
The total number of charges directly depend on sulfation levels, given that except for the 
charge contribution of the COO- groups of the glucuronic or iduronic acids in heparan 
and chondroitins, the rest of the contribution to the charge is due to the presence of the 
SO3- groups. The existence of other charged groups present on the polysaccharides, 
which is possible, is uncommon. The calculations have been made for the products used 
during the experiments and represent a fair, good average estimate for the polysaccharide 
length and charge. As will be shown in the discussion of the results by analysis of the 
graphs below, small deviations (~ 0.25 charges/dimer) of these values will not change the 
general trend that supports the hypotesis of linear dependence of adhesion with charge 
per dimer. 
 
In order to show the proposed dependence of the adhesion with charge per dimer, an 
individualized plot of adhesion versus sulfate and chain length is presented in Figures 24 
to 29 for each cell line. Charge per dimer, as shown , increases in the sequence 
KS<CSC<CSA<HS and chain length in the sequence HS<KS<CSA<CSC. 
 
It must be clarified that no intention has been made of obtaining the precise mathematical 
form of the dependence, for any case. Rather, a simple linear best fit has been plotted to 
support the central hypothesis in the case of the adhesion versus charge diagrams, and a 
“trend” line in the case of  the chain lenghts. The inclusion in these results of adhesion 
data for two more polysaccharide substrates will give enough information for the fitting 
                                                                                                                                                 
solution: Hyaluronic acid, heparitin sulfate, and keratan sulfate. Biopolymers, 1974, 13, 139-156. 
123 Cif note 1 supra. 
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values and extraction of the precise form of the mathematical relation. However, as 
shown, it has been possible to give, qualitatively, the approximate form of the relation 
and then provide a rationale for it.  
 
Figure 24 shows a plot of the adhesion vs. sulfate per dimer for MCF7 (bottom) , BT20 
(middle) and A431 (top) of non treated cells. The fact that CSC and CSA have similar 
charge values per dimer but differ in adhesion values is what provided a lead to study the 
effects of chain length on the adhesion. In the case of the MCF7 cell line, the plot shows 
a line that has been plotted assuming that the value for CSC may be higher. With that 
exception, linearity is fairly clear. 
 
Figure 25 shows a plot of the adhesion vs. sulfate per dimer for MCF7 (bottom) , BT20 
(middle) and A431 (top)  of heparin suspended cells. Again, the similarity of the lines 
between cell lines and, more importantly, between different conditions –non treated and 
heparin resuspend- substantiates the assesment made before about the existance of this 
relationship. In the case of the A431 cell line, the plot shows a line with negative slope. It 
is possible that the value for KS may be distorting the plot.  
 
That leads to the discussion of the possibility of finding cell lines or conditions where the 
adhesion does not increase or decreases with polysaccharide charge.  That situation 
indicates that a modification of conditions, or cDNA transfection changing the molecular 
expression of heparanase, may disrupt the tendency of regular cells to attach to 
polysaccharide chains depending on the charge density of the chain. 
 
Figure 26 shows a plot of the adhesion vs. sulfate per dimer for MCF7 (bottom) , BT20 
(middle) and A431 (top) of heparanase cDNA transfected cells. All plots look fairly 
similar, with similar slopes.  
 
The y intercepts in these plots may have the following significance. If the y-intercept is 
not at zero level for zero charge (assuming that the extrapolation to zero can be 
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performed), that would mean that adhesion levels do not drop to zero if the molecule is 
neutral. This residual level then can be understood as the level of adhesion of the cells 
not associated to the specific binding that provides the bulk of the adhesion numbers. If a 
mathematical relation can be deduced, this could predict the levels of adhesion of the 
homologous desulfated polysaccharide. If the y-intercept is at negative levels, that could 
mean that the cells require substrates with substantial charge density in order to be able to 
attach. 
 
This discussion is clearly understood when looking at the plots, because they have been 
constructed using adhesion levels versus sulfate groups. If the graph is plotted using total 
charge per dimer, instead of sulfate groups only, the y-intercept may cross over the zero 
level (but not necessarily in all cases). In that case, the y-intercept will show the adhesion 
levels when the total number of sulfate groups is zero. As indicated, this second type of 
plot would be more usuful in two cases: when plotting adhesion of naturally desulfated 
polysaccharides (i.e. hyaluronian) or when plotting adhesion levels of artificially 
desulfated GAGs. 
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Fig.24.  Adhesion vs sulfate per dimer graph for A431, BT20 and MCF7 non treated cells. Individualized plot of 
the adhesion vs. charge (sulfates) per dimer for A431 (top), BT20 (center) and   MCF7 (bottom) non-treated cells. 
Number of samples per GAG/substrate/cell line was nine.  
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Fig.25. Adhesion vs sulfate per dimer graph for A431, BT20 and MCF7 heparin suspended cells.  Individualized 
plot of the adhesion vs. charge (sulfates) per dimer for A431 (top), BT20 (center) and   MCF7 (bottom) heparin 
suspended cells. Number of samples per GAG/substrate/cell line was nine. 
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Fig.26. Adhesion vs sulfate per dimer graph for A431, BT20 and MCF7 cDNA transfected cells. Individualized 
plot of the adhesion vs. charge per dimer for MCF7 (top) , BT20 and A431 cDNA transfected cells. Number of samples 
per GAG/substrate/cell line was nine. 
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Figure 27 shows individualized plots of adhesion vs. GAG length for BT20 (top) and a 
proposed trend in a series with different degrees of polymerization (bottom). Obvioulsy, 
four results do not provide enough indication to construct a curve to fit the values, mainly 
because the results adjust to more than one type of curve, and what has been represented 
are two possible trends. 
 
One trend, represented in with a continous blue line and the other with a continous red 
line. In both cases cells seems to experience a limiting value for adhesion levels –that is, 
increased polysaccharide chain length will not result in an increase in the number of 
adherent cells. This limiting value is around 50-70 dimers, which in this case, assuming 1 
nm length for the dimer, gives 50-70 nm for the extended length. Also, this same curve 
type clearly indicates that a minimum length of about 8-10 dimers may be necessary to 
observe adhesion to polysaccharides.   
 
Clearly, the modulation of the adhesion levels by chain length is of lesser importance 
compare to the charge density per dimer and this dominant effect is observed in the other 
trend. The best way to prove the existence of this limiting effect would be to perform 
adhesion experiments with short chondroitins (of equal charge density) to truly observe 
adhesion behaviour independent of the charge per dimer. This proposed trend has been 
plotted in the same figure, representing what could be the adhesion number of an 
arbitrary cell line versus the degree of polimerization of an arbitrary GAG. 
 
In conclusion, a subtle relationship between cell adhesion and length of the 
polysaccharide chain may exist, but this relationship is certainly not as clear as the linear 
relationship that exists with the charge per dimer. 
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Fig.27. Adhesion vs GAG chain length.  Individualized plot of the adhesion vs. GAG length for BT20 (top) and 
proposed possible trend in a series with different degrees of polymerization.
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To summarize, the existence of a possible limiting value restricting the number of 
adherent cells to substrates containing polysaccharides by the length of the chain may 
prove interesting in several instances. Indeed, the use of very large or very short 
molecules for adhesion is not observed in nature, and quite the opposite, some very large 
molecules are used to initiate a signaling cascade to avoid adhesive contacts in cancer 
cells, for instance MUC1. It is interesting to note how, at constant charge density per 
dimer, like in the case of chondroitins, almost in all cases the longer molecule shows the 
higher level of adhesion. 
 
In previous pages it has been shown that cells may have no tendency (a possibility 
mentioned for A431 cells and/or for cDNA transfected cells) to increase adhesion when 
the charge density increases, but that the most likely linear relationship is to increase the 
adhesion. Polysaccharides may have a very high-density charge, but rarely surpassing 
four charges per dimer (i.e. heparin). Then, the range of the charge per dimer studied here 
includes the major part of the spectrum of biological polyelectrolytes. A third aspect 
included in this analysis is how the presence or absence of glucuronic acid and the levels 
of sulfation affect adhesion levels and is implicitly included in the central hypothesis 
presented here. First, the absence of a hexuronic acid in KS is directly responsible for the 
reduction in adhesion levels, because of the reduction in charge density per dimer. This 
relation is direct and clear and, along with having a medium to short chain, produces a 
GAG that has some anti-adhesive properties. That is the reason why, proteins bind 
proteoglycans in the cell surface (syndecans) using HS residues but do not do it with the 
KS chains. Second, high levels of sulfation provide the necessary charges to increase 
adhesion. It must be noted that no experiments have been performed here to compare 
adhesion levels between molecules showing different sulfation location, for instance 
between 2 and 6 sulfated heparan sulfates. Although CSA is 4 sulfated and CSC is 6 
sulfated, and both have similar charge density per dimer, the difference in chain length 
impedes any conclusion about the effect of 4 and 6 sulfation on adhesion levels. 
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5. Physical model of adhesion using the radius of gyration of the biopolymers 
 
The previous discussion has shown that there seems to be a dependence of the adhesion 
of the cells respect to the length of the biopolymer on the substrate and also respect to the 
total charge (or sulfatation level). A possible model to accommodate both parameters is 
at hand using the concept of the radius of gyration of a polymer. The intention is to 
calculate the radius of gyration of the GAGs using polymer models and then analyze how 
the adhesion of the tumor cells changes with the radius of gyration.   
 
The idea here is to apply a well known polymeric model that describes the values of the 
radius of gyration Rg as a function of the two parameters studied in the previous section: 
chain length Lc and electronic charge, that here it will identified by f and corresponding 
to the charge per disaccharide. Two main options are available: the freely jointed chain 
(FJC) and the worm-like chain model (WLC). The WLC124 model describes the polymer 
as a curved, continuous string of irregular shape but that remains linear in the range of a 
length known as persistence length Lp. Within this context, the longer the persistence 
length, the stiffer or more rod-like the polymer chain will be or resemble. In the case of 
the FJC model, the polymer is treated consisting of a specified number of segments 
joined by flexible joints with a characteristic length known as Kuhn length, which is a 
measure of the stiffness of the molecule. 
 
It is possible to use modified WLC or FJC models that account for the elasticity of the 
polymer, but the variations introduced on them will not provide significant changes in the 
results presented here for several reasons. On is the comparative high change in the 
number of adherent cells to the substrates respect to the small change of the radius of 
                                                 
124 Kratky, O.; Porod, G. . Rontgenuntersuchung aufgeloster Fadenmolekule. Recueil, 1949, 68, 1106–1122. 
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gyration. Tipically, the FJC model has been used to describe molecules that show great 
flexibility, for example oligonucleotides125, while the WLC model has been applied, for 
instance, to DNA126, that has a substantially stiffer chain. However, polysacharides have 
been described by both models but here the WLC model will be used. The GAGs used 
here are highly charged polysaccharides with large variations in their lengths and there 
are recently proposed models for the electrostatic persistence length that can be 
applicable to the them using the WLC model. In addition, in adhesion experiments there 
are not big extensions of the molecules (they are not subjected to big stretching forces) 
and then the differences between the FJC and WLC model that may appear because of 
this reason will not be of application.  
 
It can be shown (Doi, 1996; Flory, 1953) that the radius of gyration of a polymer 
molecule is given by 
 
Rg = (<r2> / 6)1/2                                                                                                       (1) 
 
Where <r2>  is the mean square end-to-end distance of the molecule. The radius of 
gyration is defined as the root-mean-square distance of an end of the chain from the 
center of gravity of the chain. Equation (1) is valid for all type of chains, ideal or real, 
and what changes between different chain statistical models is the value of <r2>. For the 
WLC model, the mean square end-to-end distance is given by 
 
<r2>WLC = 2LpLc (1 – (Lp/Lc) + (Lp/Lc) e-Lc/Lp)                                                         (2) 
 
equation where the only fit parameter is the persitence length, because the contour length 
is fixed and assumed to be well defined and given by  
                                                 
125 Lee, G.U.; Chrisey, L.A.; Colton, R.J. Direct measurement of the forces between complementary strands of DNA. 
Science 1994, 266, 771-773. 
126 Bustamante, C.; Marko, J. F.; Siggia, E. D.; Smith,  S. Entropic elasticity of l-phage DNA. Science, 1994, 265, 
 121
 
Lc = nl                                                                                                                     (3)  
 
where  l  is the disaccharide length (that corresponds to the theoretical segment of the 
chain). Equation (3) was already used in previous sections for the calculation of GAGs 
contour length. Application of the model requieres the calculation of the persistence 
length, a parameter that cannot be measured experimentally. As mentioned, in the case of 
the persistence length the chain direction is preserved on its length scale and below that 
value the polymer is considered linear. 
 
Originally, the models describing persistence lengths did not include specific terms to 
account for the effect of the ionic atmosphere surrounding the polymer backbone like in 
the case of polyectrolytes. However, Odijk127 and  Skolnick and Fixman128 introduced the 
concept of electrostatic persistence length. Essentially, the conformational properties of a 
polymer chain that contains ionizable groups may be described using the Debye-Huckel 
potential, where  electrostatic interactions in the media are screened –exponentially- with 
a length scale of the order of the Debye screening length κ-1. Apparently, the increased 
stiffness of the chains highly charged, respect to non charged chains, may be due to an 
extension of the range of interaction of different segments. The model for the persistence 
length proposed by Odijk, Skolnik and Fixman introduced a quadratic dependence of the 
electrostatic persistence length with the Debye screening length and this dependence has 
been recently modified129 to describe a semiflexible polyelectrolyte under the conditions 
of the WLC model, with a total persistence length given as 
 
                                                                                                                                                 
1599-1600. 
127 Odijk, T.  Polyelectrolytes near the rod limit J. Polym. Science, Part B,: Polym Phys.  1977, 15, 477-483. 
128 Skolnick, J.; Fixman, M. Electrostatic Persistence Length of a Wormlike Polyelectrolyte Macromolecules, 1977, 
10, 944-948. 
129 Dobrynin, A.V. Electrostatic Persistence Length of Semiflexible and Flexible Polyelectrolytes. Macromolecules, 
2005, 38, 9304-9314. 
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Lp  = L0p + Lelectp  = L0p + 0.32 (lB/l) f2κ-1                                                            (4) 
 
where  L0p is the bare persistence length (of a similar polyelectrolyte whitout charged 
groups),   Lelectp is the electrostatic persistence length, f is dissacharide charge, κ-1 is 
Debye length, (which represents the thickness of the ionic atmosphere or double layer 
surrounding the polymer), lB is the Bjerrum length, (distance at which the Coulomb 
interaction between two elementary charges in a dielectric medium of dielectric constant 
ε is equal to the thermal energt  KBT) and l is length of the dissacharide. 
 
In the situation of low forces applied to the polymers, which is of application here, the 
persistence length and the Kuhn length are related by  
 
LK  = 2Lp           (5) 
 
where it should be noted that there is no simple observable correlation between Kuhn or 
persistence lengths and real measurable quantities like the bond length or the 
disaccharide length. In order to apply the model given by equation (4) to GAGs, some 
assumptions are necessary. Values of parameters (some have been taken from the 
literature) and the assumptions made follow: 
 
• Contour lengths Lc and charges per disaccharide will be as as previously assigned, 
HS (dimers =22, charges=2.5, sulfate groups= 1.5) ; KS (dimers =32, 
charges=0.5, sulfate groups=0.5); CSA (dimers =54, charges= 2.0, sulfate 
groups=1); CSC (dimers =131, charges=1.75, sulfate groups=0.75). 
• The bare persistence length used will be 0.22 nm, taken dividing by 2 the 
persistence length of dextran (0.44 nm), a polysaccharide containing all glucose 
residues with the sequence α(1,3)-Glu-α(1,3)-Glu. 
• Debye length, using estimated values given in Israelachvili, 1992. In general κ-1 
lies bwtween the following values,  100Å (10-3 Molar solutions)  <  κ-1  < 3 Å 
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(1Molar solutions). Assuming physiological conditions of  around 0.150 Molar in 
solution, the estimated value is κ-1 ~ 0.8 nm. To observe the possible effect on the 
linearity of the adhesion of the Debye length, two other values have been used for 
calculations: 0.5 and 1.5 nm. 
• Bjerrum length 0.7 nm (value taken is for water) 
• HS is assumed to have a rod like conformation due to its high charge per dimer 
and it its assumed to be a stiff chain applying the limit of the WLC for stiff chains 
given by <r2> = L2 which is also of application for short chains. 
• CSA, CSC and KS are assumed semiflexible charged chains, applying the WLC 
full equation (2). 
 
Using the mentioned parameters, calculated values for the persistence length, the mean 
square end-to-end distance and the radius of gyration are shown in Table 12. The value of 
the Debye length that will later be used in the plots of the adhesion vs Rg is 0.8 nm. The 
other two are shown for comparison purposes. Some aspects can be commented from 
these results: 
 
- The radius of gyration increases with the square of the charge per dimer, making this 
parameter more important that the chain length. For instance, albeit the length of   CSA is 
1.5 times the length of KS, the radius is 2.5 bigger.  
- The Debye length of 0.8 nm was calculated assuming physiological conditions. When a 
Debye length smaller –0.5nm- is used, there are small changes in radius of gyration, but 
the final results keep the proportionality observed with the calculations with 0.8 nm. This 
indicates that albeit the effect of increased salt presence certainly has an impact on the 
radius of gyration, the proportionality observed between the radius of gyration of 
different GAGs with different Debye lengths doesn’t change and that will keep the 
linearity observed in the plots of the of the adhesion vs Rg .
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Table 12.  Calculated values of the radius of gyration. Results shown have been estimated using the assumptions 
made in the text. Values are shown in three groups, with variations in the Debye length and calculations of the 
persistence length and radius of gyration. 
 
 
 
 Model Parameters (nm) 
 Debye length κ-1 = 0.5 Debye length κ-1 = 0.8 Debye length κ-1 = 1.5 
GAG Lp <r2> Rg Lp <r2> Rg Lp <r2> Rg 
KS 0.248 15.87 1.62 0.264 16.94 1.68 0.304 19.45 1.80 
CSA 0.668 72.14 3.46 0.936 101.17 4.10 1.564 168.9 5.30 
CSC 0.563 147.5 4.95 0.738 201.42 5.79 1.249 327.2 7.38 
HS 0.920 302.5 7.10 1.340 484.0 8.98 2.320 907.5 12.29 
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Fig.28.  Plots of adhesion vs Rg of GAGs for non treated cells. Individualized plot of the adhesion vs. radius of 
gyration of the corresponding GAG as calculated in Table 12  for A431 (top), BT20 (center) and   MCF7 (bottom). 
Number of samples per GAG/substrate/cell line was nine.  
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Fig.29.  Plots of adhesion vs Rg of GAGs for heparin suspended cells. Individualized plot of the adhesion vs. radius 
of gyration of the corresponding GAG as calculated in Table 12  for A431 (top), BT20 (center) and   MCF7 (bottom). 
Number of samples per GAG/substrate/cell line was nine. 
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Fig.30.  Plots of adhesion vs Rg of GAGs for cDNA transfected cells. Individualized plot of the adhesion vs. radius 
of gyration of the corresponding GAG as calculated in Table 12  for A431 (top), BT20 (center) and   MCF7 (bottom). 
Number of samples per GAG/substrate/cell line was nine. 
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Figures 28, 29 and 30 shows plot of the adhesion vs. radius of gyration for MCF7 
(bottom) , BT20 (middle) and A431 (top) of non treated cells, heparin suspended cells 
and cDNA transfected cells. The values of the radius of gyration used are the ones with a 
Debye length of 0.8 nm, as mentioned previously. As is very clear, all figures are very 
similar to the figures plotted using only the charge per disaccharide. In all cases it seems 
to be a linear relationship between the adhesion of the whole cells and the calculated 
radius of gyration of the glycosaminoglycan on the substrate. 
 
The results can be analyzed in the following manner. Adhesion levels are generally 
higher for HS. Using the WLC model in the limit of stiff chains the radius of gyration is 
also high enough to make this relatively short GAG stiff and rod-like enough to allow the 
receptors in cell to have access to the disaccharide sequences to permit an increased 
adhesion. On the other side, KS, with a low value of the radius of gyration and more 
amenable to be treated as a linear semiflexible chain has a much more limited ability to 
work as a good substrate for the adhesion. In the intermediate area, CSA and CSC 
increase the adhesion levels, but in the case of CSC chain length increase does not 
correspond to similar increase in the adhesion levels. 
 
One of the difficulties to assess the correctness of this analysis is that the experiments are 
performed with whole cells and the relative variation in adhesion numbers by cell is 
comparatively much higher than the relative variations introduced by different polymer 
models, changes in the Debye length or in the total charge per disaccharide. This become 
especially more difficult with only four polysaccharides studied. 
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6. Future work 
 
This project has established basic experimental methods that will permit additional work 
in other aspects of the adhesion of these cancer cells. Here some of these additional 
aspects are mentioned. 
 
The most apparent aspect to be studied is the dependence of the static adhesion with 
increasing or decreasing GAG surface concentration. The reason behind this 
consideration is the still unclear density of GAGs present in the glycocalyx. Given our 
results, where GAG concentration depends on the concentration of APTES, increasing 
GAG concentration would be possible by using a different technique for APTES 
deposition, for instance by reflux with dry toluene. 
 
The most interesting study would be to include additional polysaccharides to precisely 
obtain the linear relationship of the adhesion vs. charge per dimer. The use of hyaluronan, 
that contains an acidic moiety but no sulfate group, can provide an idea of the 
contribution of the carboxylic group by itself and observe the effect on the adhesion 
when no sulfate group is present. To assess the effect of higher charge density in the 
sequence, heparin can be used. In addition, to completely verify the hypothesis that 
adhesion has a limiting value in the chain length, the same GAG in a series with different 
degrees of polymerization can be tested. 
 
An additional study may be conducted to analyze the effect on the adhesion when the 
medium contains additional factors, known to be present in the microenvironment of the 
glycocalyx of endothelial cells of the blood vessel of the primary tumor, and whose 
presence at different concentration may disrupt the adhesion process. Specifically, the 
effect of some proteolytic factors derived from the solubilization of the ECM and present 
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in the blood stream as well as changes in pH and ionic strength on the attachment to 
different surfaces may be analyzed130.  
 
There is abundant information to justify the study of the adhesion of cancer cells to the 
glycocalyx in the presence of these factors.  Essentially, metastatic cells produce or wait 
for a change in pH, from physiological to slightly acidic, for the cleavage of HSP and 
other PGs and the solubilization of the ECM to help them intravasate. This is clear since 
the ECM retains heparanase in an inactive form at physiological pH but after a decrease 
in pH –or maybe the presence of other factors- the enzyme regains the catalytic activity.  
 
The proteolytic factors that may be studied are mainly disaccharide or oligosaccharide 
sequences derived from GAGs, galactose, glucosamine, glucuronic acid, galatosamine 
and xylose. There is no information available in the literature about the concentrations of 
proteolytic fragments of glycosaminoglycans in microvessels or in the areas surrounding 
primary tumors but any polymer present in the media and highly sulfated could affect 
adhesion.  
 
The elevation of ionic strength can block a possible electrostatic binding between 
glycosaminoglycan/receptor, so it may also be of interest to conduct cell adhesion studies 
with changing physiological salt conditions to characterize if that could affected 
electrostatic interactions responsible for the adhesion. The reason for this test is based on 
reported results131 showing that cell attachment of lymphoma cells with heparanase 
expressed on the surface was not affected after removing 85% of all ECM sulfated 
material from endothelial cells. The results of that work suggest that heparanase mediated 
cell adhesion could happen due to the effect of net cell surface charge after interaction 
with HS, but not necessary by binding with HS. 
Another obvious aspect of interest is the study of transient adhesion. It is common 
                                                 
130 Cif. note 3, supra. 
131 Cif. note 35 supra. 
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knowledge that, previous to the attachment, viruses and cells use rolling as means to 
identify specific binding sites. Rolling of tumor cells in the presence of shear flow in the 
blood vessels may play a role in the adhesion of tumor cells. Cell rolling under shear 
flow could also be an important factor in the ability of the cancer cells to extravasate 
from the vessel into the epithelium. This is because the effectiveness of the adhesion is 
dependent on the shear force created by the fluid in the circulatory system, as has already 
been demonstrated in the ability of leukocytes to roll over surfaces132. Additional 
experimental studies for cell rolling can be performed based on the measured properties 
of the adhesion at the single molecule level.  Results of this project indicate that statically 
heparanase seems to preferentially bind heparan sulfate surfaces. However, since the 
dynamic cell adhesion role of the heparan sulfate/heparanase binding has not been 
investigated previously, these force experiments are of particular interest and constitute a 
natural extension of the work performed in this project. The relationship between the 
molecular mechanical properties, the energy landscape of the bond, and the ability to 
support rolling interactions could be investigated.  
 
Because the static adhesion of the cells is probably mediated by integrin receptors, 
additional use of function-blocking integrin antibodies to prevent adhesion could provide 
more information regarding the specificity of the bond between these receptors and 
GAGs.
                                                 
132 Chen, S.Q. An automatic braking system that stabilizes leukocyte rolling by an increase in selectin bond number 
with shear. Journal of Cell Biology, 1999, 144, 185-200. 
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7. Conclusions and key achievements 
 
The study of the processes relating glycobiology and cancer will have increased interest 
in coming years. To contribute to this trend the outcome of this study will be useful for 
investigations in cancer glycobiology using experimental methods exhibiting controlled 
carbohydrate composition, organization, and orientation, drawn from materials science 
and physics. The following paragraphs summarize the research performed in this project. 
 
Contribution to the field of glycomics 
 
As it was mentioned in the introduction, typical methods to deposit molecules have 
generally consisted in growing endothelial cells on surfaces and then eliminating part of 
the biological material via  lysis. This artificial model has permitted testing for adhesion 
between cancerous cells and GAGs found in the ECM. However, that method cannot 
study individualized interactions between cells and molecular species of choice, and 
developing a new technique that facilitates this analysis has been one of the main 
contributions in this project. 
 
There are no known reports in the literature on reactive microcontact printing of 
mucopolysaccharides as reported in this project. Given the increasing importance of the 
study of the biological processes of polysaccharides, the introduction of this surface 
functionalization technique will be helpful in expanding the field of glycomics.  
 
In essence, there are several advantages in using this type of surface: individualized study 
of molecular interactions at the molecular level –carbohydrate-carbohydrate, 
carbohydrate-protein or even carbohydrate-nucleic acid; manipulation of the density of 
the carbohydrate on the surface; manipulation of the structural composition of the 
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polysaccharide chain or use of neoglycoconjugates; and possibility of its use in 
microarray technology or in carbohydrate affinity screening. 
 
Development of novel method for preparation and characterization of biopolymeric 
surfaces. 
 
During the course of this study a new method was devised for the covalent attachment 
and patterning of glycosaminoglycans to surfaces previously coated with amino 
terminated monolayers via reductive amination. Four glycosaminoglycans –keratan 
sulfate, heparan sulfate, chondroitin sulfate A and chondroitin sulfate B, and one 
proteoglycan, perlecan- were succesfully deposited and characterized. Confirmation of 
attachment and patterning of the molecules to the substrates was demonstrated with 
fluorescence imaging, while variations in silane agent concentrations and adjustment in 
deposition times provided information on the best concentration and incubation times. 
Characterization of the surfaces was performed by ellipsometric measurements and a 
representative patterned surface was characterized and imaged by AFM. 
 
These functionalized surfaces may prove useful in the study of the adhesive properties of 
cells, and provide the basis for the development of a model system to study cancer cell 
adhesion to glycans and a broader list of polysaccharides, beyond glycosaminoglycans. 
 
A novel experimental technique for the determination of glycosaminoglycan surface 
densities was developped. 
 
In the absence of instrumentation for spectroscopy measurements, this surface density 
radiolabeling technique can be used with any N-acetylated sugar surface exposing an 
amino terminated monolayer. The method uses known chemical procedures for 
glycosaminoglycan chain cleavage. Surface coverage is an important parameter in the 
replication of surfaces with immobilized biopolymers. Changes in surface densities of the 
deposited biopolymers affects the biological activity of the molecules and thus the 
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adhesion of the cancer cells.  
 
Results indicate that APTES surfaces had a density of amino groups of 0.14 groups/nm2 
and that this surface density did not change with increased incubation times –from 15’ to 
12 hours- indicating that silanization was performed with uniform layers. GAGs surface 
densities were in the range of 500 to 1000 sites per μm2 depending on GAG. Glycocalyx 
meshwork descriptions assume a 20 nm spacing between chains, thus the density 
obtained was one order of magnitude lower than the known density existing in the 
glycocalyx.  
 
In vitro experimental measurement of adhesion levels of cancer cells to the 
glycosaminoglycan functionalized surfaces was performed. 
 
Specifically, the comparative analysis of the static adhesion of the cells in regular 
conditions, in medium containing heparin and with heparanase cDNA transfected cells 
was performed. A combination of six substrates and three different conditions provided 
information om cancer cell adhesion for eighteen different cell environments. Results 
indicate that heparanase participates in the cancer cell adhesion to the 
glycosaminoglycans but that this is not the only mechanism for the adhesion.  
 
Two are the factors that indicate heparanase increases cell adhesion. First when natural 
levels of heparanase in the cell are high, like in A431, then the adhesion of cDNA 
transfected cells surpasses or equals in all cases the adhesion of non transfected cells. 
Second, when natural low expression is found, like in MCF7 cells, the overexpression 
does not produce enough heparanase to make the level of adhesion higher than non 
transfected cells, but always better than heparin suspended cells. 
 
Non treated, heparin suspended and heparanase cDNA transfected cells show reduced 
levels of attachment to keratan sulfate substrates. 
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Results show that keratan sulfate substrates have anti-adhesive properties and that this 
properties are common for all cell lines and conditions. 
 
Preferential adhesion of cells is to heparan sulfate substrates  
 
After adjusting for equal surface density of GAGs and, excluding the values for control 
substrates (glass and APTES), non treated cells showed preferential adhesion to heparan 
sulfate substrates in all cell lines. Heparin suspended cells show preferential adhesion to 
HS for MCF7 and BT20 and to CSA for A431 cells. cDNA transfected cells showed 
preferential adhesion to HS for BT20 and A431 cells and KS for MCF7 cells.Taken 
together, all cells showed preferential adhesion to heparan sulfate substrates. 
Physiologically, the reasons behind these preferences may lie in the type and location of 
the tumor and in the distribution of the glycosaminoglycans in tissues. 
 
Heparin effectively reduces adhesion while cDNA transfection shows mixed results 
 
Heparin had the effect of reducing the adhesion of the cells to all substrates in all cell 
lines with respect to the levels of non-treated cells, with the exception of KS for A431 
cells and CSA and APTES for BT20 cells. Results also show that heparanase 
overexpression only partially enhances cell adhesion respect to non-treated cells. 
However, cDNA transfection always increased adhesion levels with respect to heparin 
suspended cells. 
 
It is hypothesized that the adhesion of cells to polysaccharide chains has a linear 
dependence with the number of charges per disaccharide.  
 
Results indicate that the relationship may be cell dependent and that usually takes the 
form of linear increase when the number of charges (sulfate groups) per disaccharide 
increases. These results are valid within the range of 0.5 to 2 sulfates (0.5 to 3 charges) 
per dimer. Extrapolation of values to zero charge per dimer –neutral polysaccharides- 
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indicates that adhesion will not necessarily drop to zero levels when the molecule is 
neutral. These residual levels of adhesion are also cell line dependent. 
 
It is hypothesized that the adhesion of cells to polysaccharide chains have a maximum 
and a minimum limiting values in the length of the chain.  
 
Also depending on the specific cell line, for very short oligosaccharides, below 8-10 
disaccharides, adhesion levels may drop to zero. Cell adhesion will increase up to a 
limiting value of 50-70 disaccharides and beyond that mark the adhesion levels of the 
cells will remain constant, independent of the chain length, at least up to 130 
disaccharides.  
 
All togheter, adhesion of whole cells shows linear dependence with the radius of gyration 
of glycosaminoglycans on the susbtrates. 
 
Using the WLC model for polymer chains to calculate the radius of gyration of the GAGs 
on the substrates it has been possible to confirm that the adhesion of the cells has a linear 
response with the radius of gyration and is essentially controlled by the charge per dimer 
–with a secondary contributing effect due to the chain length- and that this dominating 
mechanism is not eliminated when the cells are subjected to heparanase cDNA 
transfection or resuspension in media with heparin. 
 
The purpose here has been to show that there is a physical underlying mechanism 
dominating the adhesion of the cells, mainly the charge per dimer, that works 
independently of the conditions the cells are subjected to, and that this mechanism can be 
studied and observed macroscopically working with whole cells, not necesarily having to 
use isolated molecules as receptors. This in fact indicates that the cellular environmental 
conditions may play a small role in the adhesion process and are unable –at least to the 
extent studied here- to disrupt cellular adhesion. 
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Appendix A: Equipment 
 
Only major equipment is listed in this page.  
 
Atomic Force Microscope. Asylum Research MFP 3D AFM model with liquid tapping 
mode imaging, Q-control for cantilever resonance enhancement,  reduced coherence 
length light source for reduced noise in force measurements, real time hand operated 
control over the tip placement, ability to sit atop a fluorescence microscope. 
Inverted Optical Fluorescence Microscope. Epifluorescence microscope (Nikon 
TE2000) equipped with a QImaging Retiga EX Monochrome 12-bit Digital Camera for 
fluorescence imaging 
Automatic Ellipsometer. AutoEL III Automatic Ellipsometer. Automated nulling 
ellipsometer (Rudolph Research). 
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Appendix B: Detailed Steps of the Chemical Procedures 
 
Diagrams with detailed steps of the chemical procedures used for surface 
functionalization and radiolabeling are included here. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31. Detailed reaction of silanization with APTES. 
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Appendix B: (cont.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32. Detailed reaction of reductive amination with NaBH3CN. 
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Figure 33. Detailed reaction of the procedure for radiolabeling Aptes surfaces.  A)  with [14C]-Formaldehyde and 
B) with [14C]-Acetaldehyde. 
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Figure 34. Detailed reaction of radiolabeling via enamine. 
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Figure 35. Detailed reaction of proteoglycan binding to APTES.  In A) the crosslinker and HSP are reacted on the 
surface of a patterned hydrophilic PDMS stamp with release of a N- hydroxysuccinimide.  In B) the crosslinker and 
HSP are transferred to the APTES surface with release of  an N- hydroxysuccinimide. 
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Figure 36. Detailed reaction of denitrosation.  
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Figure 37. Detailed deacetylation and deamination. The example corresponds to a chondroitin sulfate C sample. 
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